
















A neutrophil timer coordinates immune defense and vascular protection 
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Neutrophils eliminate pathogens efficiently, but can inflict severe damage to the host if they 
over-activate within blood vessels. It is unclear how immunity solves the dilemma of mounting 
an efficient anti-microbial defense while preserving vascular health. Here, we identify a 
neutrophil-intrinsic program that enables both. The gene Bmal1 regulated expression of the 
chemokine CXCL2 to induce CXCR2-dependent diurnal changes in the transcriptional and 
migratory properties of circulating neutrophils. These diurnal alterations, referred to as 
neutrophil aging, were antagonized by CXCR4 and regulated the outer topology of neutrophils 
to favor homeostatic egress from blood vessels at night, resulting in boosted anti-microbial 
activity in tissues. Mice engineered for constitutive neutrophil aging became resistant to 
infection, but the persistence of intravascular aged neutrophils predisposed to thrombo-
inflammation and death. Thus, diurnal compartmentalization of neutrophils, driven by an internal 





The capacity of neutrophils to kill pathogens but to also inflict severe damage to tissues 
suggests the existence of a protective mechanism that balances these opposing functions. Both 
anti-microbial immunity and vascular inflammation are known to follow circadian patterns (Man 
et al., 2016; Muller et al., 1989; Scheiermann et al., 2013), suggesting that such mechanism 
may be temporally regulated.  The nature of this mechanism, however, remains enigmatic.  
While studying neutrophils in the steady-state we previously identified a natural phenotypic shift 
of circulating neutrophils that followed a strict diurnal regime (Casanova-Acebes et al., 2013). 
Neutrophils released from the bone marrow display high levels of CD62L that are progressively 
and spontaneously reduced during the day, while the levels of CXCR4 increase prior their 
natural egress from blood, or clearance (Casanova-Acebes et al., 2013). In a small cohort of 
healthy volunteers, we confirmed that similar diurnal phenotypic changes occur in circulating 
neutrophils in humans, indicating conservation of this phenomenon across species (Figure 
S1A). This process, referred to as neutrophil aging, has been proposed to be regulated by the 
gut microbiota and to favor a pro-inflammatory phenotype that predisposes to vascular 
inflammation (Zhang et al., 2015). Contrasting with this model of extrinsically-driven neutrophil 
aging, various lines of evidence have shown that intrinsic programs controlled by the molecular 
clock also regulate the properties of immune cells, including macrophages, monocytes or T cells 
(Druzd et al., 2017; Nguyen et al., 2013; Silver et al., 2012). Because the mechanisms 
regulating aging and the consequences of this process in physiology remain uncertain, we set 
out to explore whether neutrophils are endowed with an intrinsic program that controls diurnal 
aging, tunes their anti-microbial functions, and limits vascular inflammation. 
By comparing the transcriptome of circulating neutrophils at different diurnal times we found 
regulation of clock-related genes and the CXCR2 signaling pathway. We show that Bmal1 (brain 
and muscle aryl hydrocarbon receptor nuclear translocator (ARNT)-like 1; encoded by Arntl) 
regulated expression of CXCL2, a CXCR2 ligand that controlled neutrophil aging in a cell-
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autonomous manner. Deletion of Bmal1 or Cxcr2 from neutrophils prevented phenotypic aging, 
whereas deletion of Cxcr4, a negative regulator of CXCR2 signaling (Martin et al., 2003), 
resulted in unrestrained aging. Analyses of mice lacking these genes in neutrophils, or wild-type 
mice at different diurnal times, demonstrated that aging disrupts cytoskeletal integrity to 
specifically prevent rolling and accumulation in inflamed areas, without affecting the homeostatic 
migration of aged neutrophils into naïve tissues at night. We show that this temporal regulation 
of neutrophil trafficking regulated diurnal responses to infections, while at the same time 
clearing neutrophils out of the bloodstream thereby protecting the vasculature from inflammatory 
injury. These findings uncover a mechanism that protects host tissues even in the presence of a 
fully competent anti-microbial immunity, is intrinsic to neutrophils, and that may explain the 
circadian susceptibility of mammals to cardiovascular disease. 
 
Results 
A neutrophil-intrinsic timer drives diurnal aging 
In healthy mice, the number of aged neutrophils in blood follows diurnal patterns with a peak at 
around zeitgeber time 5 (ZT5; i.e. 5 hours after the onset of light), while non-aged neutrophils 
(referred to as “fresh”) predominate at ZT13 (Casanova-Acebes et al., 2013). These diurnal 
patterns persisted in constant darkness and could be entrained by a light-shift (Figure S1B-C), 
indicating that neutrophil aging is a bona fide circadian process. To identify genetic programs 
that were temporally regulated in neutrophils we first compared the transcriptomes of circulating 
neutrophils purified from wild-type mice at these two times. We identified changes in over 1300 
genes related to pathways of inflammation, migration and apoptosis (Figure 1A-B and Table 
S1), which suggested natural modulation of these processes during the day. We validated 
expression for a group of selected genes by quantitative PCR (Figure S1D).  Given the diurnal 
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pattern of aging, we also inspected genes of the molecular clock as they are known to regulate 
diurnal rhythms of the immune system (Man et al., 2016; Scheiermann et al., 2013). Expression 
of several clock-related genes, including Arntl (encoding Bmal1) or Clock increased at ZT5, 
while others like Per2 were decreased at this time (Figure 1B and S1D-E).  Interestingly, 
transcriptional analyses at multiple times of day revealed circadian oscillations for all these 
genes in circulating neutrophils (Figure 1C). Our RNA sequencing analyses further 
demonstrated reduced expression of Sell (encoding CD62L) at ZT5, but no changes for Cxcr4 
(Figure 1B). We also noticed reduced expression of Cxcr2 at ZT5 (Figure 1B), whose 
expression, like the clock genes, displayed a diurnal pattern (Figure 1D). This finding was 
intriguing because CXCR2 agonists induced phenotypic changes in neutrophils that resembled 
those seen during natural aging, namely reductions in CXCR2 and CD62L surface levels 
(Figure 1E and Figure S1F). 
Guided by the temporal expression patterns of this set of genes and their reported functions in 
various immune settings (Eash et al., 2010; Mei et al., 2012; Nguyen et al., 2013), we predicted 
that Bmal1 and CXCR2 might be required for diurnal neutrophil aging. Although CXCR4 did not 
present transcriptional oscillations (Figure 1D), its surface levels on neutrophils changed 
diurnally (Figure 1E and (Casanova-Acebes et al., 2013)) and CXCR4 is known to antagonize 
CXCR2 signaling (Martin et al., 2003), suggesting that this receptor might also contribute to 
aging. Because diurnal aging occurs in the circulation, we examined whether the main 
physiological agonists for CXCR2 and CXCR4 were present in blood at steady-state. Ligands 
for both receptors were detectable in the plasma of wild-type mice, with oscillating amounts of 
CXCL12, and low but detectable levels of CXCL2 (Figure 1F).  
To formally test the possibility that these genes regulated neutrophil aging, we generated mice 
with neutrophil-specific deficiency in Arntl, Cxcr2 or Cxcr4 (herein referred to as Bmal1N, 
CXCR2N and CXCR4N) using the MRP8CRE driver line, which resulted in robust depletion of the 
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receptors form the surface of neutrophils (Figure S2A-B). Western blot analysis of Bmal1 protein 
confirmed efficient depletion in Bmal1N neutrophils, and revealed reductions of this protein at 
ZT13 in wild-type neutrophils but unchanged levels in CXCR2N and CXCR4N neutrophils 
(Figure S2C). We then assessed surface levels of CD62L, a marker whose levels decline during 
aging ((Casanova-Acebes et al., 2013; Uhl et al., 2016; Zhang et al., 2015) and Figure 1E). To 
ensure that potential alterations were cell-intrinsic, we generated bone marrow transplant 
chimeras of wild-type and each of the mutant donors. We found elevated levels of CD62L in 
circulating neutrophils from Bmal1N and CXCR2N donors, suggesting disrupted aging in these 
mutants (Figure 2A). In contrast, CXCR4N neutrophils were low for CD62L, which suggested 
constitutive aging (Figure 2A). If these alterations were caused by disruption of diurnal aging, 
we predicted that the levels of CD62L would not change over time. Indeed, in vivo metabolic 
pulse and chase of neutrophils with BrdU demonstrated that the temporal changes in CD62L 
levels seen in wild-type neutrophils were lost in Bmal1N and CXCR4N mutants (Figure 2B).  To 
further confirm that these genes regulated the natural dynamics of aging, we measured the 
levels of CD62L through full diurnal cycles in all mutant mice. While CD62L levels exhibited 
diurnal oscillations in wild-type neutrophils, all three mutants presented disrupted patterns, with 
Bmal1N mutants showing a complete loss of rhythmicity (Figure 2C). Accordingly, the levels of 
CXCR4 in Bmal1N neutrophils also lost diurnal oscillations (not shown). 
To dissect the antagonistic role of CXCR4 in aging, we pre-treated wild-type neutrophils with 
CXCL12, the main ligand for CXCR4, before exposing them to a CXCR2 agonist. Given the 
constitutively aged status of CXCR4-deficient neutrophils, we hypothesized that stimulation of 
CXCR4 would prevent CXCR2-dependent responses. Indeed, CXCL12 blunted both the 
reductions in CD62L and chemotaxis elicited through CXCR2 (Figure S2D). In addition, 
neutrophils expressing CXCR4WHIM, a hyper-signaling variant of CXCR4 (Balabanian et al., 
2012), displayed constitutive elevations in CD62L levels (Figure S2E), a finding consistent with 
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the notion that CXCR4 signaling prevents neutrophil aging. Combined, these data indicated that 
Bmal1 and CXCR2 promote diurnal aging, and that CXCR4 prevents it. 
 
Aging-driven transcriptional programs 
Having identified Bmal1, CXCR2 and CXCR4 as intrinsic regulators of diurnal aging, we used 
the neutrophil-specific mutant mice as models to examine how programmed diurnal aging 
impacted neutrophil physiology. We first performed transcriptomic analyses of blood neutrophils 
extracted from Bmal1N , CXCR2N and CXCR4N mice at ZT5, and compared them with the 
profiles of wild-type neutrophils at ZT5 and ZT13. Principal component analyses of the five 
groups revealed that neutrophils that displayed a CD62LHI fresh phenotype clustered together 
(including wild-type at ZT13, Bmal1N and CXCR2N), whereas those that shared an aged 
phenotype (wild-type at ZT5 and CXCR4N) separated from the “fresh” cluster (Figure 2D), with 
many genes differentially regulated among the fresh and aged groups (Figure S2F). Consistent 
with a role in diurnal aging, when we contrasted the transcriptomes of wild-type and mutant 
mice at both ZT5 and ZT13 we found that the diurnal changes in gene expression of wild-type 
neutrophils were absent or blunted in Bmal1N and CXCR4N neutrophils (Figure S2G). These 
findings aligned with the phenotypic data (Figure 2A and 2C) and, importantly, defined diurnal 
aging as a global transcriptional program of circulating neutrophils that occurs naturally during 
the day, and that could be recapitulated in the mutant mice. 
We next focused our attention on genetic programs that consistently changed when 
independently interrogating the effect of time (ZT5 vs. ZT13) and genotype (Bmal1N vs. 
CXCR4N). We noticed prominent regulation of the IL-8 signaling pathway (a ligand for human 
CXCR2; Figure S2H), which was in line with our previous results and further suggested 
engagement of CXCR2 during aging. Interestingly, analyses of our sequencing data revealed 
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that among aging-related genes only expression of Cxcl2, a CXCR2 ligand expressed by 
neutrophils (Li et al., 2016), was reduced in Bmal1N relative to wild-type neutrophils (Figure 
2E), suggesting that this chemokine could provide a link between Bmal1 and CXCR2 during 
aging. Indeed, chromatin immunoprecipitation (ChIP) assays with wild-type neutrophils revealed 
that Bmal1 bound predicted E-box elements in the promoter regions not only of known target 
clock genes (Per2 and Nr1d1), but also of the Cxcl2 gene (Figure 2F). More importantly, 
analysis of bone marrow chimeras from wild-type and Cxcl2 donors confirmed that this 
chemokine was required for neutrophil aging in a cell-autonomous manner (Figure 2G).  
Consistent with this finding, in vivo blockade of CXCL2, but not CXCL1 (another ligand for 
CXCR2), blunted the aging phenotype of wild-type neutrophils without affecting CXCR2N 
mutants (Figure S2I). These findings explained the defective aging seen in Bmal1N neutrophils 
(Figure 2A), and revealed that Bmal1-driven production of CXCL2 controlled neutrophil aging 
through autocrine CXCR2 signaling.  
To independently assess the cell-intrinsic nature of aging, we tracked the kinetics of fresh 
neutrophils transferred into recipient mice at ZT5 (i.e., at the time of maximal aging). While host 
mice became enriched in fresh neutrophils over time, the transferred neutrophils became 
progressively aged (Figure S2J), further supporting that neutrophil aging is intrinsically driven.  
Taken together, these findings supported a model whereby diurnal neutrophil aging is driven by 
Bmal1 through regulation of Cxcl2 expression. This chemokine in turn triggers autocrine CXCR2 
signaling to drive changes associated with aging, whereas CXCR4 antagonizes these signals to 
prevent aging (Figure 2H). Importantly, because the CXCR4 ligand CXCL12 is produced by 
multiple cell types but not by neutrophils (Figure 2E), we conclude that both cell-intrinsic and –




Aging-regulated migration of neutrophils 
The transcriptomic analyses additionally identified pathways that changed significantly (-log (p-
value)>1.3), including cytokine signaling, activation of nuclear receptors, toll-like receptor 
signaling, leukocyte extravasation or actin cytoskeleton signaling (Figure 1A and Figure S2H). 
Because many of these pathways ultimately regulate the migration of neutrophils into tissues to 
exert immune functions, we investigated the in vivo trafficking patterns associated with 
neutrophil aging.  
We considered two migratory modalities that are relevant in neutrophil physiology: migration into 
healthy tissues (or clearance, a process that follows diurnal cycles (Casanova-Acebes et al., 
2018; Scheiermann et al., 2012)), and migration into inflamed tissues. We took advantage of our 
neutrophil-specific mouse models to exclude cell-extrinsic factors influenced by time, such as 
diurnal changes in adhesion molecules reported on endothelial cells (Scheiermann et al., 2012). 
In addition, because CXCR2 plays prominent roles in multiple homeostatic and inflammatory 
scenarios that may not be related to aging, we restricted our subsequent analyses to Bmal1 and 
CXCR4 mutants as models for fresh and aged neutrophils, respectively. 
We first generated parabiotic pairs of wild-type and mutant mice to compare the migration 
efficiency of fresh (Bmal1N) and aged (CXCR4N) neutrophils relative to wild-type neutrophils in 
the same physiological context (Figure 3A). We found that homeostatic clearance of Bmal1N 
neutrophils into multiple tissues of wild-type partners was strongly impaired, whereas it was 
unaffected for CXCR4N neutrophils (Figure 3B), indicating that neutrophil aging was required 
for clearance into tissues. 
We next examined the migration of the aging mutant neutrophils into inflamed tissues using 
zymosan-induced peritonitis in the parabiotic pairs. Surprisingly, we found the opposite 
response: enhanced migration of Bmal1N fresh neutrophils and reduced infiltration by CXCR4N 
aged neutrophils (Figure 3C). Using an independent model of constitutive aging (mice lacking 
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endothelial selectins, or PEdKO mice; (Casanova-Acebes et al., 2013)) we confirmed that aged 
neutrophils displayed intact clearance at steady-state (Figure S3A), but impaired migration to 
inflamed tissues (Figure 3B). In contrast, impaired aging of neutrophils expressing the hyper-
signaling CXCR4WHIM mutation resulted in enhanced migration to inflamed tissues (Fig.S2E). 
Whole-mount imaging of inflamed cremasteric muscles from transplantation chimeras further 
confirmed the differential capacity of fresh and aged neutrophils to infiltrate inflamed tissues 
relative to wild-type cells after correction for relative numbers in blood (Figure 3D-E), and this 
became even more prominent when constitutively aged and fresh neutrophils expressing 
different fluorescent proteins were simultaneously compared within the same mouse (Figure 
3F). Importantly, these findings aligned with enhanced inflammatory recruitment of wild-type 
neutrophils when they were phenotypically fresh (ZT13), and this diurnal preference was lost in 
Bmal1N and CXCR4N mutant mice (Figure S3B). These data revealed that aging profoundly 
influences the migratory capacity of neutrophils by causing a diurnal switch of migratory patterns 
from inflammatory (fresh neutrophils at ZT13 and Bmal1N) to homeostatic (aged neutrophils at 
ZT5 and CXCR4N). 
 
Surface topology and rolling efficiency are regulated during diurnal aging 
To search for the mechanisms underlying the distinct migratory patterns of fresh and aged 
neutrophils, we examined the different steps of the recruitment cascade (rolling, adhesion and 
extravasation) in the cremasteric microcirculation by intravital microscopy (Figure 4A). We found 
elevated rolling, adhesion and extravasation efficiencies of Bmal1N neutrophils, and significant 
reductions for CXCR4N neutrophils (Figure 4B). The defects in the recruitment cascade of 
CXCR4N aged neutrophils could be independently reproduced in PEdKO-derived aged 
neutrophils (Figure S4A and Movie S1). In contrast to rolling, however, the crawling dynamics of 
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neutrophils on the vessel wall and within tissues (Figure S4B-C), as well as the migration to 
various chemoattractants (Figure S4D), were comparable among all groups. To determine 
whether the alterations in rolling seen in mutant cells also occurred in wild-type neutrophils, and 
to avoid confounding diurnal changes in parenchymal cells, we imaged auto-perfused flow 
chambers coated with P-selectin alone or together with ICAM-1 and CXCL1, and connected to 
the circulation of wild-type mice at ZT5 and ZT13 (Figure S4E). In agreement with the data in 
the mutant models, we found elevated rolling efficiencies and subsequent adhesion for 
neutrophils at ZT13 relative to ZT5 (Figure S4F), indicating that diurnal changes in rolling and 
adhesion were cell-intrinsic. Combined, these data suggested that diurnal aging impaired 
inflammatory recruitment by specifically targeting rolling, a rate-limiting step during leukocyte 
recruitment (Ley et al., 2007).  
Because rolling is largely mediated by endothelial selectins, the data implied that aging targeted 
selectin ligands on neutrophils. Unexpectedly, binding analyses using soluble P- and E-selectin 
antibody chimeras revealed only modest changes in selectin binding activity regardless of time 
of day or genetic background (Figure S4G), suggesting that biosynthesis of selectin ligands was 
unlikely to cause the loss of rolling during aging. Effective engagement of selectins under flow, 
however, additionally demands correct topology at the neutrophil’s surface to optimize ligand 
presentation at the tip of microvilli, a type of membrane protrusion that relies on a network of 
cortical actin (Finger et al., 1996; Simon et al., 2007; von Andrian et al., 1995). Analyses of actin 
distribution by immunofluorescence staining and surface topology by scanning electron 
microscopy revealed that aged neutrophils displayed dramatic reductions in cortical -actin, 
which coincided with reduced number of microvilli both in wild-type mice at ZT5 (Figure 4C-D), 
and in genetically-induced aged mice (CXCR4N; Figure S4H-I). These data revealed that 




Homeostatic migration does not require rolling 
These observations, however, failed to explain why poorly-rolling aged neutrophils maintained 
an intact capacity to enter non-inflamed tissues under homeostasis (Figure 3B). To address this 
question, we analyzed homeostatic and inflammatory recruitment in control mice, and in mice in 
which vessels do not support rolling due to the lack of endothelial selections (PEdKO mice; 
(Frenette et al., 1996)). While adhesion to inflamed vessels required selectin-mediated rolling as 
expected, we were surprised to find that spontaneous adhesion during homeostatic recruitment 
to the skin occurred even in the absence of rolling (Figure 4E). Video analyses of the dermal 
microvasculature at times of clearance (ZT9) confirmed that neutrophils arrested suddenly, 
without the need of a preceding rolling step (Figure 4F and Movie S2).  Thus, neutrophil aging 
maintains homeostatic clearance but prevents inflammatory recruitment by disabling selectin-
mediated rolling (Figure 4G).  
To determine how the differential migratory properties of fresh and aged neutrophils affected 
tissue injury, we induced ischemic inflammation of the brain by occlusion of the middle cerebral 
artery. Because the brain is devoid of neutrophils at steady-state (Figure S4J), this model allows 
measuring the contribution of infiltrating neutrophils to tissue damage (Cuartero et al., 2013; 
Sreeramkumar et al., 2014). In line with our prediction, brain injury was only exacerbated in 
Bmal1∆N mice enriched in fresh neutrophils (Figure S4K), suggesting that preferential migration 
of fresh neutrophils during inflammation contributes to tissue injury. 
 
Diurnal aging boosts anti-microbial defense 
The observations so far raised the possibility that regulation of neutrophil migration during the 
day might be a primary role of diurnal aging; it could drive compartmentalization of aged 
neutrophils into tissues at night in anticipation of pathogens potentially breaking into tissues, 
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while at the same time reducing their numbers within vessels to minimize injury when the 
chance of immune activation is higher.  
To address this possibility, we analyzed the diurnal dynamics of aged neutrophils in the 
circulation of wild-type and mutant mice throughout the day. The analyses revealed striking 
differences: in wild-type mice aged neutrophils peaked at ZT5 and disappeared at ZT13, while 
in Bmal1∆N mice they displayed non-oscillating low levels, and CXCR4N animals presented 
constitutively high numbers of aged neutrophils in blood (Figure 5A). Interestingly, the absolute 
number of neutrophils maintained normal oscillations in the blood of Bmal1N mutants (Figure 
S5A), indicating that neutrophil numbers and aging are regulated through different mechanisms. 
We therefore used these mouse models to determine how the diurnal migratory fluxes driven by 
neutrophil aging regulated immune defense and vascular health.  
We first infected mice with Candida albicans, using a protocol that allows systemic spread, 
targets the kidneys, and is controlled by neutrophils (Lionakis et al., 2011). Wild-type mice 
displayed diurnal patterns of response to infection, with increased resistance at ZT13 as defined 
by reduced weight loss, fungal load in kidneys and improved survival, (Figure 5B and Figure 
S5B-C). Importantly, the initial time of infection was critical for the long-term immune response 
because the effect could be seen several days after infection. Resistance to Candida at ZT13 
coincided with more neutrophils in naïve kidneys and fewer in blood (Figure S5D-E), suggesting 
that their presence in tissues at the time of infection conferred protection. Remarkably, we found 
that the diurnal variation in susceptibility to Candida infection was abolished in Bmal1∆N mice 
(Figure 5C), indicating that neutrophil aging was needed to anticipate the infection. These 
observations predicted that mice with constitutively aged neutrophils clearing into tissues might 
perform better against infection. In agreement with this possibility, CXCR4N mice had more 
neutrophils in naïve kidneys and manifested remarkable resistance to infection and reduced 
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fungal spread (Figure 5D-F). However, because we noted that CXCR4N mice displayed 
neutrophilia (Figure S5A), this observation could be alternatively explained by elevated numbers 
rather than the aging status of neutrophils. To discriminate between these possibilities, we 
treated wild-type mice with a single injection of the CXCR4 antagonist AMD3100, a treatment 
that causes acute neutrophilia (Devi et al., 2013) but did not induce aging (Figure S5F-G). 
Despite neutrophil counts that were even higher than those in CXCR4N mice, AMD3100-treated 
mice were as susceptible to Candida infection as untreated wild-type mice (Figure 5G), 
indicating that the aging status rather than the number of neutrophils conferred protection 
against Candida. In addition, the capacity of fresh (ZT13 or Bmal1N) and aged (ZT5 and 
CXCR4N) neutrophils to phagocytose Candida conidia, to produce reactive oxygen species 
(Figure S5H-J), to secrete cytokines (Figure S5K) as well as their metabolic status 
(mitochondrial respiration and glycolysis; not shown) were similar to wild-type cells, which 
supported the contention that neutrophil migration, rather than other cellular processes, was the 
relevant process regulated by aging. We obtained evidence of similar diurnal variations in the 
response to bacterial sepsis, which was also lost in Bmal1N mice (Figure S5L), further revealing 
a general influence of neutrophil aging in responses to infection. Thus, aging-driven clearance 
of neutrophils into tissues orchestrates anti-microbial defense. 
 
Constitutive neutrophil aging predisposes to vascular inflammation 
To define whether diurnal neutrophil aging additionally conferred protection to vessels, we used 
a model of acute myocardial infarction (AMI) induced by ischemia-reperfusion of the left anterior 
descending coronary artery. In this model, early inflammation originates intravascularly without 
prior neutrophil extravasation (Vinten-Johansen, 2004). Similar to infections, the extent of 
cardiac damage in wild-type mice displayed diurnal variations, with larger infarct size when 
surgery was performed at ZT5, after correction for the area at risk (Figure 6A-B and Figure 
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S6A). Accordingly, infarct sizes after only one hour of reperfusion were remarkably larger in 
CXCR4∆N mice and smaller in Bmal1N mice (Figure 6C), and this correlated with all CXCR4∆N 
mice succumbing (11 of 11)  by 24 hours post-surgery (Figure 6D). This dramatic response 
agreed with the reported involvement of aged neutrophils in other forms of vascular 
inflammation (Zhang et al., 2015), and again was not caused by increased numbers of 
circulating neutrophils in CXCR4∆N mice because treatment of wild-type mice with AMD3100 did 
not aggravate myocardial injury (Figure 6E). These data indicated that the excessive presence 
of aged neutrophils in the circulation was detrimental for the myocardial tissue after vascular 
ischemia and reperfusion, and that their diurnal clearance was protective.  
Although massive cardiomyocyte death driven by intravascular aged neutrophils seemed to 
account for the extreme susceptibility of CXCR4N mice during AMI, we examined other potential 
mechanisms by which aged neutrophils might exacerbate vascular injury. Using a model of 
ischemia-reperfusion in the cremasteric muscle that allows high resolution live imaging of 
affected vessels, we found disseminated thrombi in microvessels of CXCR4N mice (Figure S6C 
and Movie S3). Depletion of neutrophils in CXCR4N mice prevented thrombi formation and 
improved survival after infarction (Figure S6B-C), indicating that both responses were mediated 
by neutrophils. Although neutrophil extracellular traps (NET) can promote thrombosis (Fuchs et 
al., 2010), they were not responsible for the response of CXCR4N mice because two different 
NET inhibitors failed to prevent thrombi formation in reperfused venules (Figure S6D). In 
addition, endothelial proliferation and apoptosis as well as vascular permeability were not 
affected at baseline across multiple tissues, including hearts, of Bmal1N and CXCR4N mice 
(Figure S6E-G), indicating that aging did not directly compromise basal vascular health prior the 
ischemic insult. 
Overall, these observations are consistent with the known circadian susceptibility of humans to 
AMI at specific times of day (Muller et al., 1989), particularly in the early morning when aged 
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neutrophils appear in the human circulation (Figure S1A). In addition, because aged neutrophils 
predominate at ZT5 and CXCR4N mice display constant high numbers of aged neutrophils in 
blood (Figure 5A), the data suggests that diurnal compartmentalization of aged neutrophils into 
tissues and out of the circulation confers vascular protection (Figure 6F and Movie S4). 
 
Discussion 
Mammalian immunity is not constant in number or quality throughout the day, as it adapts to 
varying diurnal challenges from the environment, including the chance of exposure to infectious 
pathogens (Man et al., 2016).  Likewise, it has been long appreciated that damage to the 
cardiovascular system, in both humans and model organisms, follows circadian patterns (Muller 
et al., 1989; Scheiermann et al., 2013).  Because neutrophils are major mediators of anti-
microbial defense and vascular inflammation, we predicted that the diurnal variations in both 
processes could be mechanistically explained by the existence of a neutrophil-intrinsic temporal 
program (referred here as “timer”) that regulated their activity through the day. In this study, we 
identify and characterize this program and show that it underlies the circadian susceptibility of 
mice to infection and vascular inflammation. Although we cannot formally exclude other 
mechanisms that control the diurnal properties of neutrophils, we have failed to find defects in 
neutrophil aging in mice with defective ROS production (data not shown) or depleted of 
microbiota (Figure S6H-K), both of which had been previously associated with neutrophil 
senescence or aging, respectively (Harbort et al., 2015; Zhang et al., 2015). 
An internal timer that coordinates defense and inflammation 
We have found that the diurnal program of neutrophils is coordinated by the circadian-
associated protein Bmal1 in coordination with two chemokine receptors, CXCR2 which drives 
aging, and CXCR4 which antagonizes it. Multiple functional assays allowed us to confirm that 
time-of-day differences in wild-type cells could be faithfully recapitulated by the respective 
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mutants: Bmal1N cells resembled night (fresh) neutrophils whereas CXCR4N mutants behave 
similar to daytime (aged) neutrophils. Before release into the bloodstream, maturing neutrophils 
are retained within the marrow in an environment with high CXCR4/CXCL12 signaling (Eash et 
al., 2010; Eash et al., 2009), which raises the intriguing possibility that this diurnal timer may be 
inhibited until neutrophils are released into blood. Once in blood, functional analyses of mice in 
which we disabled each component of this timer revealed that preferential invasion of inflamed 
or naïve tissues is compartmentalized in time. Under steady-state conditions, neutrophils 
released from the marrow gradually lose their ability to enter inflammatory sites and prepare for 
clearance into tissues. This migratory switch is intrinsically regulated, but it likely coordinates 
with extrinsic programs because disruption of rhythms in vascular cells can also affect the 
diurnal entry of leukocytes in tissues (Scheiermann et al., 2012) and because CXCL12, which is 
not produced by neutrophils, negatively regulates diurnal aging through CXCR4.  
We find that one potential benefit of diurnal infiltration into naïve tissues is to optimize immune 
defense, as demonstrated by the loss of diurnal oscillations in the response against fungal or 
bacterial infections when Bmal1 was deleted from neutrophils. Removal of CXCR4, the negative 
regulator of the neutrophil timer, instead caused unrestrained aging and enhanced anti-
microbial responses, while at the same time precipitating severe thrombo-inflammatory 
reactions following ischemia-reperfusion. In contrast, Bmal1N mutants displayed attenuated 
damage during myocardial infarction, altogether indicating that an intact neutrophil clock is 
important to balance anti-microbial defense and cardiovascular inflammation.  
An additional, unexpected finding was that the aging status, rather than the number of 
circulating neutrophils, was the parameter that best predicted immune and inflammatory 
responses, at least in the models used in this study. This finding agrees with reports suggesting 
that aged neutrophils favor vascular inflammation (Zhang et al., 2015), and with the growing 
appreciation that heterogeneity among neutrophils is functionally relevant (Silvestre-Roig et al., 
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2016). In particular, we report here a type of heterogeneity that, unlike that found in 
autoimmunity or cancer (Nicolas-Avila et al., 2017), associates with time-of-day in the steady-
state. We do not know whether the aging phenotypes reported here relate with low/high density 
neutrophils or other subsets found in specific scenarios, yet defining this relationship may be 
key to predict possible time-dependent contributions of neutrophils during cancer or chronic 
inflammation.  
The diurnal timer as a regulator of migration 
Among the various transcriptional pathways activated during aging we identified those related to 
leukocyte extravasation and actin cytoskeleton signaling, an observation that allowed us to 
identify disruption of cortical actin polymerization as a key molecular event linking diurnal aging 
with alterations in the migratory properties of neutrophils. While the mechanisms underlying 
these cytoskeletal changes remain to be elucidated, this observation is consistent with early 
studies showing disrupted actin polymerization on human CD62LLO neutrophils (Tanji-Matsuba 
et al., 1998). Diurnal loss of microvilli was particularly relevant because these structures allow 
presentation of glycoconjugate ligands to endothelial selectins under flow (von Andrian et al., 
1995), thus explaining the dramatic loss of rolling and migration of aged neutrophils to inflamed 
areas. At the same time, loss of microvilli might conceivably enhance the exposure of 2 
integrins present on the cell body (Erlandsen et al., 1993) and favor rolling-independent arrest 
as seen in the naïve dermal microvasculature. We find it intriguing that a similar behavior of 
constitutive adhesion in non-inflamed vessels is displayed by patrolling monocytes (Auffray et 
al., 2007), suggesting that this mechanism could be a common property of myeloid leukocytes 
endowed with homeostatic surveillance roles. These observations should incite revision of the 
classical recruitment cascade, which for myeloid leukocytes has been almost exclusively 




A diurnal clock or a timer? 
Overall, our findings are consistent with a model in which the oscillatory nature of the aging 
program enables alert states of neutrophils that are useful to anticipate infections, but must be 
shut down when the risk of infection is low to prevent damage to the vasculature. Interestingly, 
Bmal1-driven aging of neutrophils may not necessarily adjust to behavioral rhythms since we 
find that neutrophil aging peaks in the morning in both humans and mice, which are species with 
opposed activity periods. We therefore propose that a major purpose of aging could be to 
ensure temporal separation of neutrophil-mediated responses within vessels from those in 
tissues, thereby optimizing defense without compromising vascular health. 
The diurnal aging pattern of neutrophils aligns with studies showing temporally gated responses 
for other leukocyte subsets, including monocytes, macrophages or Th17 cells (Nguyen et al., 
2013; Silver et al., 2012; Yu et al., 2013), which may be useful to temporally concentrate 
immune response against specific pathogens in different tissues (Tognini et al., 2017). Different 
from these other types of leukocytes, however, the existence of a circadian program in 
neutrophils was not intuitive because their lifetime in the circulation is generally accepted to be 
less than one day (Summers et al., 2010), which implies that there cannot be true circadian 
oscillations of gene expression within a given neutrophil. Further, at present we do not know 
whether aging is regulated by the transcriptional properties of Bmal1 or by the core circadian 
clock.  For these reasons, we envision this system to function like a cellular timer (rather than a 
true circadian clock) that resets with every new wave of neutrophils released from the bone 
marrow. In other words, for short-lived cells such as neutrophils, the clock appears to regulate 
oscillations on a population scale, by acting as a timer at the cellular level. 
Therapeutic manipulation of the neutrophil timer 
Given the high prevalence of infections and cardiovascular disease, a final question is whether 
the identification of a diurnal program in neutrophils could offer therapeutic alternatives for these 
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life-threatening complications. In principle, targeting the pro-aging receptor (CXCR2) or the anti-
aging receptor (CXCR4) with specific agonists might allow pharmacological and transient 
manipulation of the timer. This type of “chrono-programming” of neutrophils could allow the 
generation of phenotypes that promote defense or protect the vasculature, as needed. We 
expect that manipulation of the timer will not have detrimental consequences because animals 
with impaired or enhanced neutrophil aging do not present gross anomalies or spontaneous 
susceptibility to disease at baseline, at least under specific-pathogen free conditions (data not 
shown). Thus, for humans at risk of cardiovascular events it might be advisable to block aging, 
whereas immune-compromised patients susceptible to infections might benefit from drugs that 
promote aging. We are currently exploring strategies that exploit the unique temporal properties 
of neutrophils.    
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Figure 1. Cell-intrinsic rhythms in circulating neutrophils. See also Figure S1. 
(A) Molecular pathways differentially regulated in circulating wild-type neutrophils at ZT5 vs. ZT13. 
Comparisons are presented as z-score values. 
(B) Heat map of selected genes at ZT5 vs ZT13, including genes of the circadian clock and genes 
encoding proteins related to migration and inflammation. The color scale indicates fold changes 
of expression for each gene.  
(C) Diurnal expression of the indicated clock genes in neutrophils isolated from the circulation of 
wild-type mice at the indicated zeitgeber times. Shaded areas represent night; n=2-6 mice per 
time point. 
(D) Diurnal expression of Cxcr2 and Cxcr4 in circulating wild-type neutrophils at the indicated 
times; n=2-6 mice per time point. The diurnal curves are repeated (dashed lines) to better 
appreciate the pattern. 
(E) Surface levels of CXCR4, CXCR2 and CD62L at different diurnal times measured by flow 
cytometry; n=5 mice. Highlighted is the time of aging (ZT1 to ZT9), when CD62L and CXCR2 
levels go down and CXCR4 goes up. The diurnal curves are repeated (dashed lines) to better 
appreciate the pattern. 
(F) Diurnal levels of CXCL2 and CXCL12 in the plasma of wild-type mice; n=5-10 mice per time 
point. The diurnal curves are repeated (dashed lines) to better appreciate the pattern. 
All values are presented as mean ± SEM. P values were determined by amplitude vs. zero t-test 






Figure 2. Bma1, CXCR2 and CXCR4 form a diurnal clock in neutrophils. See also Figure S2. 
(A) Surface expression of CD62L in wild-type and mutant neutrophils at ZT5. Cytometric data was 
obtained from transplant chimeras of wild-type with each mutant. Bars at right show median 
fluorescence intensity; n=14-30 mice per group.  
(B) In vivo BrdU labeling of neutrophils followed by analysis of CD62L in BrdU+ cells 2 and 5 days 
after injection. Note that as labeled neutrophils enter the bloodstream, they lose CD62L over time 
in WT mice, but not in Bmal1N and CXCR4N mutants. Data is normalized to day 2 levels in each 
group; n=3-5 mice per group.  
(C) Diurnal levels of CD62L in circulating neutrophils in wild-type and mutant mice, as determined 
by flow cytometry. The times when neutrophils are phenotypically fresh or aged are indicated on 
top; n=3-10 mice per time point. P values were determined by amplitude vs. zero t-test analyses. 
(D) Principal component analyses of differentially expressed genes in circulating neutrophils from 
wild-type neutrophils at ZT5 and ZT13, and Bmal1N, CXCR2N and CXCR4N mutants at ZT5.  
(E-G) Bmal1-regulated expression of CXCL2 controls aging. (E) Heat-map showing differential 
expression of aging-related genes in wild-type and Bmal1N neutrophils. Expression of Cxcl1 and 
Cxcl12 was undetectable. Data are from triplicate samples of each group obtained at ZT5. (F) 
Experimental design and ChIP analyses of Bmal1 binding to E-box-containing promoter regions 
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of Cxcl2, Per2 and Nr1d1 in wild-type and Bmal1N neutrophils.(G) Experimental setup and 
phenotype of Cxcl2 neutrophils in transplantation chimeras. Cxcl2 neutrophils display 
elevated CD62L expression and enhanced migration to zymosan-treated peritoneum, both of 
which are consistent with disrupted aging.  
(H) Model of neutrophil aging: CXCR2 signaling drives aging, while CXCR4 antagonizes these 
signals and prevents it. Bmal1 regulates Cxcl2 expression to promote autocrine CXCR2 signaling 
and aging.  
Except where indicated, all values are mean ± SEM. **; p<0.01; ***, p<0.001 as determined by 






Figure 3. Diurnal aging impairs inflammatory recruitment but favors homeostatic 
clearance. See also Figure S3. 
(A) Experimental setup to test homeostatic or inflammatory recruitment in the indicated parabiotic 
pairs. Mutant neutrophils that enter tissues of their wild-typeRED partners (expressing DsRed) 
allowed estimation of their migratory capacity relative to wild-type cells.  
(B)  Quantification of Bmal1N (left) and CXCR4N (right) neutrophils cleared in multiple tissues of 
wild-type partners at ZT5; values are adjusted to ratios in blood and normalized to wild-type 
neutrophils cleared in wild-type partners; n=3-8 mice.  
(C) Quantification of control and mutant neutrophils that infiltrate the inflamed peritoneum of wild-
type parabiotic partners at ZT5; n=3-5 mice.  
(D-E) Whole-mount staining of TNF-treated cremaster muscles from transplant chimeras of wild-
type and Bmal1N donors (D) or wild-type and CXCR4N donors (E), showing extravasated 




(F) Whole-mount staining as in (D), comparing constitutively fresh and aged neutrophils in 
Bmal1N mice (fresh; red) set in parabiosis with PEdKOGFP (aged; green) partners. The relative 
infiltration of each partner is quantified in the right bar-graph. Scale bars for (D-F), 70 m. Insets 
show details of the differential infiltration of the two types of neutrophils in each experiment; scale 
bars, 10 m.  
All bars show mean ± SEM. *, p<0.05; **; p<0.01; ***, p<0.001 as determined by unpaired (B) or 





Figure 4. Microvilli collapse and impaired rolling are hallmarks of aged neutrophils. See 
also Figure S4. 
(A) Strategy for competitive recruitment of neutrophils to inflamed tissues using bone marrow 
chimeras, at ZT5.  
(B) Relative frequencies of rolling, adherent and extravasated fresh (Bmal1N) and aged 
(CXCR4N) neutrophils, normalized to wild-type controls in chimeric mice; n=30-61 venules from 
5-6 mice.  
(C) Immunofluoresence staining of -actin in wild-type neutrophils at ZT5 and ZT13, and 
frequency of neutrophils with cortical distribution of actin; n=324-330 cells per group.  
(D) Scanning electron micrographs of wild-type neutrophils at ZT5 and ZT13, and quantification 
of the number of villi on their surface. Scale bar, 5 m; n=23-29 cells per group.  
(E) Rolling and adhesion of neutrophils on cremasteric venules after treatment with TNF- 
(Inflammation), or on naïve dermal microvessels at ZT9-13 (Steady-state) in wild-type or PEdKO 
mice. n=50-55 venules from 4-5 mice (steady-state), and 25-27 venules from 3-5 mice (inflamed 
cremaster). ND, none detected.  
(F) Kinetics of neutrophils (Ly6G+; yellow arrows) prior firm arrest on dermal microvessels in the 
steady-state. Left, sequential intravital frames of the same vessels of wild-type or PEdKO mice 
with neutrophils arresting in the last sequence (reverse arrows). Right, flow/roll dynamics of 
neutrophils before firm arrest; n=10 cells shown per group.  
(G) Model for the preferential recruitment of fresh and aged neutrophils into inflamed or naïve 
tissues, respectively.   
Bars show mean ± SEM. *, p<0.05; **; p<0.01; ***, p<0.001 as determined by paired (B), or 






Figure 5. Neutrophil aging confers diurnal protection against infection. See also Figure S5. 
(A) Diurnal numbers of CD62LLO aged neutrophils in the blood of wild-type, Bmal1N and CXCR4N 
mice; n = 3-6 mice. See also Figure S5A. 
(B-C) Weight loss kinetics of wild-type (B) and Bmal1N mice (C) infected with C. albicans at ZT5 
or ZT13; n=5-21 mice per time point.  
(D) Weight loss curves comparing wild-type, Bmal1N and CXCR4N mice infected at ZT5; n=12-
14 mice.  
(E) Fungal burden at day 5 in the kidneys from the mice in (D), normalized to WT.  
(F) Number of neutrophils in the kidneys of non-infected mice; n=4 mice per group.  
(G) Kinetics of weight-loss in control- or AMD-treated wild-type mice after systemic C. albicans 
infection at ZT5. The dashed line show weight loss in CXCR4N mice shown in Fig.4D for 
reference. Bars at right show fungal burden in kidneys at day 5 post-infection; n=10 mice 
Data are shown as mean ± SEM. **; p<0.01; ***, p<0.001; n.s., not significant, as determined by 
amplitude vs. zero t-test (A), two-way ANOVA (B-D.G), one-way ANOVA with Dunnett’s 







Figure 6. Aged neutrophils aggravate myocardial infarction. See also Figure S6. 
(A) Representative images showing infarcted areas of hearts from wild-type mice subjected to 
transient occlusion of the coronary artery followed by 1 hour reperfusion at ZT5 or ZT13, or in 
the indicated mutant mice at ZT5. Dotted yellow lines highlight areas of dead myocardium; n=4-
8 mice per group.  
(B) Quantification of infarct sizes for wild-type mice at different diurnal times, after correction for 
areas at risk (AAR; see related Figure S5); n=5-8 mice. 
(C) Quantification of infarct sizes in wild-type, Bmal1N and CXCR4N mice at ZT5, after 
correction for AAR (see related Figure S5); n=4-8 mice.  
(D) Survival curves of wild-type, Bmal1N and CXCR4N mice subjected to myocardial infarction 
at ZT5; n=9-11 mice.  
(E) Representative images showing infarcted areas of hearts from untreated or AMD3100-
treated wild-type mice, and CXCR4N mice. Surgeries were performed at ZT5 and dead 
myocardium is highlighted as in (A). Bars at right show quantification of infarcted areas in the 
same groups; n=4-5 mice. 
Bars show mean ± SEM. *; p<0.05; ***, p<0.001; n.s., not significant, as determined by one-way 
ANOVA with Dunnett’s multigroup correction (C, E), unpaired t-test analysis (B), and Log-rank 
test (D) 
(F) Summary of molecular events regulating neutrophil aging, and the consequence of deleting 
regulators of aging (Bmal1 and CXCR4) in the dynamics and strength of diurnal defense and 
vascular injury. Defective aging (Bmal1N) impairs the evening boost in anti-microbial defense 
but protects from vascular injury, whereas constitutive aging (CXCR4N) enhances the response 






CONTACT FOR REAGENT AND RESOURCE SHARING 
Reagents used in this study are readily available from the noted commercial suppliers in the 
method itself. Further information and requests for other resources and reagents should be 
directed to and will be fulfilled by the Lead Contact: Andrés Hidalgo (ahidalgo@cnic.es) 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
Mice 
All experiments were performed in 7 to 18 week-old male C57BL/6 mice kept in a specific 
pathogen-free facility at Centro Nacional de Investigaciones Cardiovasculares (CNIC) under a 
12h light/12h dark schedule (lights on at 7am, off at 7pm), with water and chow available ad 
libitum. To generate mice with neutrophil-specific deficiency, we crossed Arntlfl/fl (kindly provided 
by S. Benitah) (Janich et al., 2011), Cxcr4 fl/fl (Nie et al., 2004) or Cxcr2 fl/f (Schloss et al., 2016) 
with hMRP8CRE mice (Passegue et al., 2004), Cxcr4WHIM mice with a hyper-signalling form of 
CXCR4 have been described (Balabanian et al., 2012) and were used as donors to generate BM 
chimeras. Cxcl2 mice were obtained from Jackson. In some control experiments we crossed 
Cxcr2fl/f mice with the Ly6GCRE mice (Hasenberg et al., 2015). Mice deficient in P an E-selectins 
(Sele and Selp; PEdKO) have been previously described (Frenette et al., 1996). To obtain 
reporter mice for intravital microscopy (IVM) studies, we crossed the PEdKO with transgenic mice 
expressing DsRed under the control of the β-actin promoter (DsRedTg; (Vintersten et al., 2004)) 
or with the Lyz2GFP reporter mouse (PEdKOGFP mice)(Faust et al., 2000). Both were also used in 
wild-type reporters for some intravital imaging experiments. In control experiments, we confirmed 
that wild-type mice used as controls yielded a similar phenotype compared with hMRP8CRE alone, 
Arntlfl/fl and Cxcr4fl/fl mice (not shown). No specific randomization method was followed in this 
study. All experimental procedures were approved by the Animal Care and Ethics Committee of 
CNIC and the regional authorities.   
 
Human studies 
The study comprised blood from 12 healthy volunteers withdrawn at 12am, 4pm, 8pm, 12pm, 4am 
and 8am. The study complied with current Spanish legislation on clinical research in humans and 
was approved by the Ethics Committee for Clinical Research of Hospital Universitario de la 




Analysis of human samples 
Total blood obtained from 12 healthy volunteers at 12am, 4pm, 8pm, 12pm, 4am and 8am and 
erythrocytes lysed in hypotonic buffer. Cells were incubated in 100μl PBS buffer containing 2 mM 
EDTA and 1% BSA (PEB buffer) with the following antibodies: anti-CXCR4-allophycocianin (APC; 
clone 12G5), anti-CD11b-FITC (clone ICRF44; both from eBiosciences), anti-CD16-pacific blue 
(clone 3G8), anti-CD62L-phycoerythrin (PE; clone DREG56), anti-CD11c-APC and 7AAD (all 
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from BD Biosciences). Cells were washed and analysed in a Canto flow cytometer at the Hospital 
de la Princesa, Madrid. 
 
Parabiosis 
We followed previously published procedures (Casanova-Acebes et al., 2013). Briefly, 
anesthetized mice were shaved and matched incisions were made from the olecranon to the knee 
joint, then olecranon and knee were attached by a single suture from one mouse to the other, 
using 5-0 polypropylene, and the dorsal and ventral skins were stitched by continuous suture. 
Analyses were done 4 to 6 weeks after surgery. 
 
Cytometry and cell sorting 
Cytometric analyses were performed using a Sony SP6800 Spectral Analyzer (Sony 
Biotechnology, Japan) or a LSRII Fortessa. For human sample cytometry we used a Canto flow 
cytometer (BD BioSciences). All cell sorting experiments were performed using an FACS Aria cell 
sorter (BD Biosciences), except the circadian sorting of blood neutrophils for qPCR analysis, 
which was performed using a Sony SH800S Cell Sorter. In all cases we obtained purities > 95%. 
All analyses, except for human samples, were done at the Cellomics Unit of the CNIC. All 
antibodies and streptavidin conjugates used in this study are listed in Table S2. 
 
Table S2. List of antibodies used in this study. 
Antibody  Clone Species Manufacturer 
CXCR4-APC 12G5 Human eBioscience 
CD11b-FITC ICRF44 Human eBioscience 
CD16-Pacific Blue 3G8 Human BD 
CD62L-PE DREG56 Human BD 
CD11c-APC B-ly6 Human BD 
Ly6G-AF647 1A8 Mouse eBioscience 
Ly6G-Dylight 450 1A8 Mouse BioXcell (conjugated in-
house) Ly6G-Dylight 650 1A8 Mouse BioXcell (conjugated in-
house) Ly6G-FITC 1A8 Mouse eBioscience 
CD45-PerCP-Cy5.5 30-F11 Mouse Biolegend 
CD11b-PE M1/70 Mouse Tonbo Biosciences 
CD11b-FITC M1/70 Mouse BD 
CXCR2-PerCP-Cy5.5 SA044G4 Mouse Biolegend 
CXCR4-APC 2B11 Mouse eBioscience 
CD41-PE MWReg30 Mouse eBioscience 
Ly6C-FITC HK1.4 Mouse Biolegend 
CD62L-APC MEL-14 Mouse eBioscience 
CD62L-FITC MEL-14 Mouse eBioscience 
CD11b-BV510 M1/70 Mouse Biolegend 
CD31-APC 390 Mouse eBioscience 
Ki-67-e660 SolA15 
 
Mouse Thermo Fisher 
 
Whole mount staining of excised cremaster muscles 
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Excised cremaster muscles were fixed in 4% paraformaldehyde at 4ºC overnight. Fixed samples 
were washed 3 times in PBS containing 0.5% Triton-x 100 (PBST) and blocked for 2 h in PBST 
25% FBS at room temperature with shaking. Staining of neutrophils was performed using a 
biotinylated anti-Mrp14 antibody (clone 2B10 kindly provided by Dr. N. Hogg, Cancer Research 
UK, London) and blood vessels with an anti-CD31 antibody (BD Biosciences) in 10% FBS-PBST 
overnight at 4ºC with shaking. Cremaster muscles were then washed and incubated with 
secondary antibody (goat anti-rabbit-Alexa 405 or –Alexa 647; Life Technologies) and Alexa-488 
conjugated Streptavidin in 10%FBS-PBST for 4h at room temperature. Samples were then 
washed and mounted in Mowiol 4-88 (Mw 31,000; Sigma). Imaging of whole-mount intestines 
was performed using a Leica SP8 X confocal microscopy system coupled to a DMI6000 inverted 
microscope, with 10x (HC PL Fluotar 10x/0.3 Dry) or 63x (HC PL Apo CS2 63x/1.4 OIL) 
magnification objectives. For in-depth quantification, large Z-stack and panoramic-stitched 
images were taken with a Nikon A1R confocal system coupled to a Nikon Eclipse-Ti inverted 
microscope with the following lines: Diode 402nm Argon Laser 457, 476, 488, 514nm Diode 
561nm HeNe Laser 642nm using a Plan Apo 10x/0,45 dry objective and the software NIS 
Elements AR 4.30.02 (Build 1053 LO, 64 bits, Nikon Instruments, Tokyo, Japan) for acquisition 
of confocal 3D tile-scan images of the whole cremaster muscle, which were afterwards analysed 
using Imaris (Bitplane, Zurich, Switzerland). All imaging was performed at the Microscopy & 
Dynamic Imaging Unit of CNIC. 
 
RNA isolation, reverse transcription and rtPCR. 
Total RNA was prepared with the RNA Extraction RNeasy Plus Mini-kit (QIAGEN) and RNA was 
reverse-transcribed with the High-Capacity cDNA Reverse Transcription kit (Applied Biosystems; 
Carlsbad, CA) according to the manufacturer’s protocol. Real-time quantitative PCR (SYBR-
green, Applied Biosystems) assays were performed with an Applied Biosystems 7900HT Fast 
Real-Time PCR System sequencer detector. Expression was normalized to the expression of the 
36b4 housekeeping gene. Primer sequences are listed in the Table S3. 
 
Chromatin immunoprecipitation (ChIP). 
Neutrophils were sorted from the bone marrow as indicated previously and fixed in 0.75% 
formaldehyde for 10 min at room temperature. Formaldehyde was then quenched with glycine 
(final concentration 0.26 M) for 5 min. After washing twice with cold PBS, cells were pelleted and 
frozen at -80°C. Each sample was lysed in 0.25 ml of lysis buffer (1% SDS, 10 Mm EDTA, 50 mM 
Tris-HCl pH 8, 1 mM PMSF, 5 μg/ml leupeptin/aprotinin, 1 μg/ml pepstatin A, 10mM NaF, 10 mM 
sodium orthovanadate, and 10 mM β-glycerophosphate) for 30 min with rotation at room 
temperature. Lysates were sonicated using the Diagenode Bioruptor sonication system 
(Diagenode, Bioruptor UCD-200TM-EX). Each sample was sonicated for two rounds of six cycles 
(30s ON and 30s OFF) at the high power setting to obtain DNA fragments between 500 and 1000 
bp. After sonication, samples were centrifuged to remove insoluble debris, supernatants were 
collected and 5% of each sample was separated to use as a measure of chromatin input for 
normalization. The rest of the sample was diluted 1/10 in ChIP dilution buffer (1% TritonX-100, 20 
mM Tris-HCl, pH 8, 2 mM EDTA, 150 mM NaCl, 1 mM PMSF, 5 μg/ml leupeptin, 5 μg/ml aprotinin, 
1 μg/ml pepstatin A, 10 mM NaF, 10 mM sodium orthovanadate, and 10 mM β-glycerophosphate) 
for immunoprecipitation. Samples were precleared with protein A Sepharose beads (GE 
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Healthcare, 17-0780-01) that were previously pre-adsorbed with fish sperm DNA (Roche, 11 467 
140 001) and bovine serum albumin (New England Biolabs, Ref. B9001S) for 1 hour at 4°C. Anti-
Bmal1 antibody (ChIP Grade (ab3350)) was added to the lysates after removing the preclearing 
beads and incubated overnight at 4°C. Pre-adsorbed protein A Sepharose beads were then 
added, incubated for 1 hour at 4°C, and then washed three times with ChIP washing buffer (0.1% 
SDS, 1% TX-100, 20 mM Tris-HCl, pH 8, 2 mM EDTA, and 150 mM NaCl) and once with final 
washing buffer (0.1% SDS, 1% TX-100, 20 mM Tris-HCl pH 8, 2 mM EDTA, and 500 mM NaCl). 
To elute DNA, beads were gently shaken with 200 μl elution buffer (1% SDS and 100 mM 
NaHCO3) for 45 min at room temperature. To reverse the crosslinking, samples were incubated 
overnight at 65°C. Then samples were incubated with 3 μl RNase (Roche, 11119915001) 30 min 
at 37°C prior to the addition of 8 μl of Proteinase K (Roche, 3115828001) for 1 hour at 50°C and 
DNA was purified by ethanol precipitation. Immunoprecipitated chromatins and their respective 
inputs before immunoprecipitation were analyzed by RT-qPCR using the primers listed in Table 
S3. The primers for the Cxcl2, Per2 and Nr1d1 promoter regions were designed in the vicinity of 
E-box sequences. 
 
Table S3. List of primers used for quantitative PCR and ChIP analyses. 
Csf3r 
Forward  CTGATCTTCTTGCTACTCCCCA 
Reverse  GGTGTAGTTCAAGTGAGGCAG 
Il1b 
Forward  AGTGAGGAGAATGACCTGTTC 
Reverse  CGAGATGCTGCTGTGAGATT 
Sell 
Forward  TACATTGCCCAAAAGCCCTTAT 
Reverse  CATCGTTCCATTTCCCAGAGTC 
Cxcr4 
Forward  TCAGTGGCTGACCTCCTCTT 
Reverse  CTTGGCCTTTGACTGTTGGT 
Mcl1 
Forward  AAAGGCGGCTGCATAAGTC 
Reverse  TGGCGGTATAGGTCGTCCTC 
Cxcr2 
Forward  TCTGGCATGCCCTCTATTCTG 
Reverse  AAGGTAACCTCCTTCACGTAT 
Arntl 
Forward  AGAGGCGTCGGGACAAAATGAACAG 
Reverse  AACAGCCATCCTTAGCACGGTGA 
Clock 
Forward  CCTATCCTACCTTGGCCACACA 
Reverse  TCCCGTGGAGCAACCTAGAT 
Per2 
Forward  CCATCCACAAGAAGATCCTAC 
Reverse  GCTCCACGGGTTGATGAAGC 
Nr1d1 
Forward  CTTCATCCTCCTCCTCCTTCTA 
Reverse  GTAATGTTGCTTGTGCCCTTG 
36b4 
Forward  ACTGGTCTAGGACCCGAGAAG 
Reverse  TCCCACCTTGTCTCCAGTCT 
Cxcl2 
(ChIP) 
Forward  CCCAGTGTCTTCTCCTACAGG 
Reverse  GGCTATCCAGGGAGACACTC  
Per2 
(ChIP) 
Forward  GGCACTCCGACCAATGGC 
Reverse  CGTCTGTCCCTTGCTCGG 
Nr1d1 
(ChIP) 
Forward  ACACACTCTCTGCTCTTCCC 




Intravital imaging of the mouse skin 
For intravital microscopy of the dermal microcirculation, the dorsal side of the ear of anesthetized 
mice was mounted on a custom-built support, and we acquired images from several venules in 2 
minute-long time-lapse videos at 3 s intervals. We used the VIVO system built by 3i (Intelligent 
Imaging Innovations, Dever, CO) upon an Axio Examiner Z.1 workstation (Zeiss, Oberkochen, 
Germany) and mounted on a 3D motorized stage (Sutter Instrument, Novato, CA). The system 
was equipped with a CoolLED pE widefield fluorescence LED light source (CoolLED Ltd. UK) and 
a quad pass filter cube with Semrock Di01-R405/488/561/635 dichroic and FF01-
446/523/600/677 emitter. A plan-apochromat 40x W NA1.0 objective (Zeiss) was used and 
images were collected with a CoolSnap HQ2 camera (Photometrics, Tucson, AZ). The system 
was run on a Dell Precision T7500 computer system (Dell Inc., Round Rock, TX) using the 
SlideBook software (Intelligent Imaging Innovations). Acquisitions were made at ZT5, ZT9 or 
ZT13 and neutrophils were stained with an AF647-conjugated anti-Ly6G antibody (clone 1A8, 
BioXcell), while blood vessels were visualized using red fluorescent Dextran (Molecular Probes). 
In some groups, anti-P and E-selectin antibodies or Rat IgG control antibody (25 μg/mouse) were 
injected 2h before imaging. Quantification was done using the ImageJ (NIH, Bethesda, MD). Cells 
were considered adhered if they remained stationary on the venule for over 30 seconds. Vessel 
diameters were measured using the ImageJ software (Schindelin et al., 2015) to normalize the 
number of adherent cells. 
 
Intravital microscopy of the cremaster muscle 
Intravital microscopy of the cremaster muscle after TNFα stimulation (R&D Systems, 0.5μg 
intrascrotal injection) was performed as previously reported(Hidalgo et al., 2009) using the VIVO 
system indicated above. For confocal IVM, we used laser stacks for 488, 561 and 640nm beams 
coupled with a confocal scanner (Yokogawa CSUX-A1; Yokogawa, Japan) and images were 
acquired with 0.5μm Z-intervals. The SlideBook software was used for acquisition and analysis. 
Ten to twenty venules segments per mouse were analysed 150 to 210 min after TNF-α treatment 
in multiple fluorescence channels (Cy3/561 for PE, FITC/488 for FITC and Cy5/640 for APC) and 
bright-field images with 1x1 or 2×2 binning with 3 second interval for 2 min on each field of view. 
For double staining with PE- and FITC-conjugated antibodies, acquisition was facilitated in single 
(FITC) and quadrant (PE) filters in order to avoid bleed-through of fluorescent signals between 
channels. For the visualization of leukocytes, fluorescently labelled anti-Ly6G-APC, anti-Ly6C-
FITC and anti-CD62L-APC antibodies were injected intravenously at 1 g/mouse.  
For analysis of rolling and adhered cells to the inflamed endothelium we used the SlideBook 
software. Counts of rolling or adhered cells in 2 minute captures (captured at 3 second intervals) 
were normalized using the width of the vessel to allow comparison among all vessels. For 
adhesion or rolling efficiency indices, this data was compared with the frequency of free-flowing 
WT and experimental cells in the blood for each mouse, which was obtained from cytometric 
analysis of blood neutrophils for each parabiont or BM chimeric mouse. Kinetic parameters for 
crawling neutrophils were calculated using ImageJ, with the help of the Manual Tracking plugin 
(Fabrice Cordelières, Institut Curie, France) and the Chemotaxis and Migration Tool (Gerhard 
Trapp and Elias Horn, ibidi GmbH, Germany). Analyses of extravasated neutrophil were 
performed on large tile-scans of whole-mounted cremaster muscles with Imaris (Bitplane AG, 
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Switzerland). We performed blind automatic counting of extravasated neutrophils by masking out 
the vessels using CD31+ fluorescence (on the BMT WT:Bmal1∆N, WT:CXCR4∆N chimeras and 
PEdKO:Bmal1∆N parabionts) or manually delimiting the vessels using brightfield or laminin 
fluorescence (on PEdKO-WT parabionts). Kinetic parameters for extravasated neutrophils were 
obtained in the DsRedTg with PEdKO-LysMGFP parabionts using automatic tracking of cells with 
Imaris. 
 
Intravital imaging of ischemia/reperfusion injury 
Mouse cremaster were prepared as indicated without TNF-α stimulation. Upon exteriorization of 
the muscle we intravenously injected fluorescent antibodies to label cellular populations. Ly6G-
APC (clone 1A8; BioXcell) for neutrophils, CD41-PE (eBioscience) for platelets, Ly6C-FITC 
(Biolegend) and CD62L-APC (BD Bioscience). Ischemia was achieved by occlusion of the 
incoming and outgoing vessels by clamping the tissue connecting the muscle and the animal’s 
body with a 15mm Micro Serrefine clamp (Fine Science Tools, Heidelberg, Germany) for 45 
minutes. Reperfusion was achieved by removal of the clamp. In some experiments neutrophils 
were depleted prior ischemia by injecting an anti-Ly6G-antibody (see below). Recordings were 
made with 3 second interval for 2 minutes for each field of view. Imaging was performed before 
and during ischemia, and during reperfusion. Some mice were treated intravenously with 300μg 
of Cl-amidine (Cayman Chemical Company, Ann Arbor) 1h before imaging, or with 500μg DNAse 
I (Roche, Basel, Switzerland) immediately before imaging. 
 
Analysis of neutrophil clearance in the steady-state 
11 to 18 week-old DsRedTg mice were analysed after 1 month in parabiosis with non-fluorescent 
CXCR2∆N, CXCR4∆N, Bmal∆N and PEdKO mice or wild-type controls. The blood of each WT mice 
was analysed and used to obtain the ratio of neutrophils derived from each partner. Mice were 
sacrificed with CO2 and carefully perfused with 30 ml of PBS to remove all blood. Tissues (white 
adipose tissue or WAT, large intestine, liver, lung, skin and spleen) were extracted and kept in 
cold PBS (except liver, kept at room temperature in HBSS) and processed immediately. Skin, 
large intestine (colon), lung and WAT were digested in HBSS with liberase (1U/ml, Roche) and 
DNAse I (1 mU/ml, Sigma) for 30 min at 37°C. Bone marrow and spleen were mechanically 
dissociated to prepare single-cell suspensions by flushing and straining, respectively. Enrichment 
of leukocytes in liver was performed by centrifugation using a 36% Percoll (GE Healthcare, diluted 
in HBSS) gradient. Colons were pre-incubated with HBSS containing 5mM EDTA for 45 min at 
37°C before digestion to remove epithelial cells. Blood counts were analysed in an automated 
hemocytometer (Abacus Junior, Diatron; Holliston, USA) and blood red blood cells (RBC) lysed 
in a hypotonic buffer. Single-cell suspensions from tissues were incubated with fluorescently-
conjugated antibodies against CD45, CD11b and Ly6G (BioXcell) and analysed in a Sony SP6800 
Spectral Analyzer. DsRed+ Ly6Ghi cells and DsRedNEG Ly6GHI cells discriminated host- 
(DsRedTg) from partner-derived neutrophils. To normalize values between the different parabiotic 
pairs we corrected the ratios of host vs. partner-derived neutrophils in each tissue with the ratios 
present in blood of each parabiotic pair. Deviations from the original ratio in blood was used to 
estimate the efficiency of migration of partner-derived neutrophils in each organ. Finally, infiltration 
efficiencies were normalized to the values obtained for the DsRedTg:WT pairs, which was set as 




Quantification of neutrophil numbers in tissues 
In some experiments, we measured absolute numbers of neutrophils present in tissues (see 
Neutrophil clearance assays). Truecount beads (Truecount absolute counting tubes, BD) were 
prepared at a concentration of 10,000 beads per ml of PBS buffer. 300μl of the bead suspension 
were added to single cell suspensions stained for flow cytometry, and then neutrophil number 
values were calculated based on the number of beads per tube and corrected by the weight or 
volume of tissue analysed.  
 
Chemokine quantification in plasma 
CXCL12, CXCL1 and CXCL2 levels were measured in plasma samples taken every 4h from WT 
mice using commercially available ELISA reagents, following the manufacturer’s protocol (R&D 
Systems; Minneapolis; MN). 
 
RNA-sequencing 
Blood neutrophils were FACS sorted using by Ly6G and DAPI labelling, with typical purities > 
95%. cDNA amplification from neutrophil RNA (1275pg) and generation of index-tagged 
sequencing libraries were carried out using the Ovation® Single Cell RNA-Seq System (NuGEN® 
Technologies, San Carlos CA). Libraries were quantified using a Quant-iTTM dsDNA HS assay 
with the Q-bit fluorometer (Life Technologies, Carlsbad, California). Average library size and size 
distribution were determined using a High Sensitivity DNA assay in an Agilent 2100 Bioanalyzer 
(Agilent Technologies, Santa Clara CA). Libraries were normalized to 10nM using Tris-Cl 10mM, 
pH8.5 with 0.1% Tween 20. Libraries were applied to an Illumina flow cell for cluster generation 
(True Seq SR Cluster Kit V2 cBot) and 61 nt long, single-end reads were generated on a Genome 
Analyzer IIx, using the TruSeq SBS Kit v5 (Illumina) and following the standard RNA sequencing 
protocol. Reads were further processed using the CASAVA package (Illumina) to demultiplex 
reads according to adapter indexes and to produce fastq files. Read quality was determined with 
the application FastQC (Schageman et al., 2013). The RNA sequencing experiments were 
performed at the Genomics Unit at CNIC. 
 
Western Blotting 
Blood neutrophils were sorted based on Ly6G (clone 1A8) expression. Purified cells were lysed 
in RIPA buffer containing 50 mM Tris-HCl, pH 8; 150 mM NaCl; 1% Triton X-100; 0.5% sodium 
deoxycholate; 0.1% SDS; 1mM PMSF (Sigma) and a protease inhibitor cocktail (Sigma). Proteins 
from 2x105 lysed cells were separated by 10% SDS-PAGE and transferred onto PVDF 
membrane. Membranes were incubated overnight with antibodies against Bmal1 (Bethyl labs) 
and β-Actin (Abcam) at 1:1000 dilutions, and then thoroughly washed and incubated with HRP-
conjugated anti-rabbit or anti-mouse antibody (1:1000; GE Healthcare Life Sciences). Blots were 
visualized using the chemiluminescent Luminata Forte Western HRP Substrate (Millipore). 
 
Generation of transplant chimeras 
To address the aging status of mutants in the same physiological context as wild-type cells, we 
generated mixed bone marrow chimeras, which has the added advantage of allowing 
simultaneous staining and analysis of willd-type and mutant cells. Donor BM cells were harvested 
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from DsRedTg or experimental models by flushing the femur with PBS. Recipient wild-type 
C57BL/6 mice were lethally irradiated (two 6Gy doses, 3 h apart) before receiving 1 million bone 
marrow nucleated cells by intravenous injection. For mixed chimeras, equal numbers of 
experimental and DsRedTg BM cells were mixed before intravenous injection. Engraftment of 
recipient animals was assessed 8–10 weeks after transplantation by analysis of the percentage 
of mutant and DsRedTg leukocytes in blood by flow cytometry. 
 
Circadian analysis of aging markers and RNA extraction 
Circadian blood samples were extracted every 4 h during 24 h from wild-type or experimental 
mice, starting at ZT1 (Zeitgeber time, 1 hour after the onset of light, 7:00 at the CNIC’s animal 
facility). For circadian surface marker analysis, RBC were lysed in hypotonic lysis buffer (0.15M 
KH4Cl, 0.01M KHCO3 and 0.01M EDTA in water) and incubated 15 minutes with 0.25 μg anti-
Ly6G (1A8 clone, BioXcell), -CXCR2 (Biolegend) and -CXCR4 (eBioscience) antibodies, washed 
and analysed in a Sony SP6800 Spectral Analyser. Analysis was performed using Flowjo vX (Tree 
Star Inc, Ashland, OR). For circadian RNA assays, blood taken at above circadian time points 
was lysed for RBCs and sorted using a Sony SH800S Cell Sorter (Sony Biotechnology, Japan) 
based on viable Ly6G+ cells. RNA was extracted as indicated above. 
 
Analysis of neutrophil aging in light-dark and dark-dark light regimes. 
To check the circadian nature of neutrophil aging we compared twice a day (ZT5 and ZT13) the 
number of CD62LLO aged neutrophils for 4 consecutive days in WT mice subjected to 12h:12h 
light: dark cycles, and in mice subjected to constant darkness in a light cabinet (LFC 3-16 with 
EF700ET programmer from E. Becker & Co) starting 24h after the onset of the light schedule. We 
analysed blood neutrophils at the indicated time points by flow cytometry as indicated above.  
 
Entrainment of neutrophil aging by inverted light regime. 
We maintained wild-type mice in 12h: 12h light-dark or dark-light (inverted light cycle) regimes 
using light-cabinets (Light/ Dark Chamber LT400 from Parkbio). After 3 weeks of this inverted 
regime we analysed peripheral blood neutrophils every 6 hours for 24 hours by flow cytometry, 
as indicated above. 
 
Infection with Candida albicans 
Mice were intravenously infected with 1.5x105 C. albicans conidia (SC5314 strain) and monitored 
daily for weight loss and general health following our institutional guidance. Infections were 
performed either at ZT5 or ZT13. Kidney fungal burden was determined at day 6 post-infection 
by plating organ homogenates in serial dilutions on YPD plates (Sigma); colony-forming units 
(CFUs) were counted after growth for 48 hr at 30ºC. Flow cytometry analysis of renal leukocyte 
infiltrates was performed on cell suspensions obtained from kidney homogenates obtained by 
digestion with 0.025 mg/ml of Liberase TL (Roche) for 10 min at 37ºC and filtered through 40 μm 
cell strainers (BD PharMingen). Phenotypic analyses of renal leukocyte infiltration were performed 
by flow cytometry.  
 
Heat-killed Candida albicans (HKC) phagocytosis assay 
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Candida albicans conidia were heat-killed by boiling for 30 minutes. To quantify the phagocytic 
capacity, BM-sorted neutrophils were stained with 5 μM CFSE and exposed to labelled HKC 
labelled with 2.5 μM Cell Violet-labelled (both from Molecular probes) at a 30:1 ratio, for 15 min 
at 37º. After washing, cells were recovered on ice with PBS containing 5 mM EDTA. To remove 
bound but not internalized HKC, cells were incubated in Trypsin-EDTA (0.25%; Life Technologies) 
for 15 minutes at 37º prior to analysis by flow cytometry. Cells were fixed in 4% paraformaldehyde 
and neutrophils engulfing HKC were identified as double-positive cells for Cell Violet and CFSE. 
Cytospin preparations were also done for microscopic inspection of phagocytosis. 
 
Mouse model of acute myocardial infarction 
Male 8 to 12 week-old mice were subjected to 45 min occlusion of the left anterior descending 
(LAD) coronary artery followed by 1h reperfusion (for infarct size). For survival experiments, the 
LAD was reperfused for up to 24h and mice monitored hourly for the first 6h, and at 16, 20 and 
24h. The I/R procedure was performed as previously described (Garcia-Prieto et al., 2017). In 
some experiments mice were depleted of neutrophils as indicated below. Briefly, fully 
anesthetized animals were intubated and temperature controlled throughout the experiment at 
36.5°C to prevent hypothermic cardioprotection. Thoracotomy was then performed and the LAD 
was ligated with a nylon 8/0 monofilament suture for 45 min. The electrocardiogram was 
monitored (MP36R, Biopac Systems Inc.) to confirm total coronary artery occlusion (ST-segment 
elevation) throughout the 45 min ischemia. At the end of the ischemia, the chest was closed and 
animals were kept with 100% O2 and analgesized with buprenorphine (subcutaneous injection, 
0.1 mg/kg). For quantification of infarct size, mice were re-anesthetized and re-intubated, and the 
LAD coronary artery was re-occluded by ligating the suture in the same position as the original 
infarction. Animals were then sacrificed and 1 mL of 1% Evans Blue dye (Sigma) was infused IV 
to delineate the Area at Risk (AAR: myocardium lacking blood flow, i.e. negative for blue dye 
staining). The left ventricle (LV) was isolated, cut into transverse slices (5-7 1-mm thick slices per 
LV), and both sides were imaged. To delineate the infarcted (necrotic) myocardium, slices were 
incubated in triphenyltetrazolium chloride (TTC, Sigma) at 37 °C for 15 min. The slices were then 
re-photographed, weighed, and regions negative for Evans Blue staining (AAR) and for TTC 
(infarcted myocardium) were quantified using ImageJ (NIH, Bethesda, MD). Percentage values 
for AAR and infarcted myocardium were corrected to mg independently for each slice. Absolute 
AAR and infarct size were determined as the mg:mg ratio of AAR:LV and infarcted 
myocardium:AAR, respectively. Outcome assessment was performed blind to condition (mouse 
type, zeitgeber time or treatment). 
 
Brain ischemia 
To induce brain ischemia (without reperfusion injury) we followed previously described protocols 
(Sreeramkumar et al., 2014). Mice were anesthetized with isoflurane 1.5-2% in a mixture of 80% 
air / 20% oxygen, and body temperature was maintained at physiological levels with a heating 
pad during the surgical procedure and anaesthesia recovery. Mice were subjected to permanent 
focal cerebral ischemia (middle cerebral artery occlusion - pMCAO) through the distal occlusion 
of middle cerebral artery by ligature of the trunk just before its bifurcation between the frontal and 
parietal branches with a 9-0 suture, in combination with the occlusion of the ipsilateral common 
carotid artery. Following surgery, individual animals were returned to their cages with free access 
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to water and food. All the groups were performed and quantified in a randomized fashion by 
investigators blinded to groups. Physiological parameters were not significantly different among 
the different groups studied. Infarct size was determined by magnetic resonance imaging 48 hours 
after MCAO using a BIOSPEC BMT 47/40 (Bruker, Ettlingen, Germany). Infarct volume was 
calculated using the ImageJ software (NIH, USA) from the T2-weighted images. With the observer 
masked to the experimental conditions, the areas of the infarcted tissue (InfArea), the whole 
ipsilesional hemisphere (IpsArea) and the whole contralesional hemisphere (ContrArea) were 
delineated for each slice. Then, infarct volume, expressed as percentage of the hemisphere that 
is infarcted (%IH) was calculated using the formula: %IH = InfVol/ContrVol*100 where InfVol 
(Infarcted Tissue Volume) = ΣInfAreai / SwellingIndexi, ContrVol (Contralesional Hemisphere 
Volume) = ΣContrAreai and SwellingIndexi = IpsAreai/ContrAreai. Neutrophil quantification in 
brains was performed 48h after surgery. The ipsilateral cortex was dissected, placed in ice-cold 
PBS and dissociated into a single cell suspension by mechanical dissociation. Cell suspensions 
were filtered on 70-μm nylon mesh strainers and centrifuged at 300g for 10 min at room 
temperature. Pellets were resuspended in 8 mL of 35% Percoll and overlaid on the top of 5 ml 
HBSS. The gradient was centrifuged at 800g for 40 minutes at 4ºC and cell pellets resuspended 
for staining with anti-CD11b-FITC and anti-Ly-6G-PE antibodies (BD Bioscence). Stained cells 
were analysed in a FACSCalibur flow cytometer with CellQuest software (BD Pharmingen, San 
Jose, CA) and data was analysed using FlowJo software (Tree Star Inc, Ashland, OR). 
 
Scanning electron microscopy 
Blood from WT, Bmal1∆N and CXCR4∆N was harvested, RBC lysed and leukocytes stained with 
Ly6G (1A8, BioXcell) before sorting in a FACS Aria sorter (BD Biosciences). Sorted cells were 
immediately centrifuged and fixed using 4% PFA plus 2.5% glutaraldehyde in PBS for 2h at 4ºC. 
Cells were then dehydrated by serial 5 min incubations in increasing concentrations of ethanol, 
(30%>50%>70%>80%>90%>100%). Samples were dried in an automated critical point dryer 
(Leica EM CDP 300) and then coated in a rotary-pumped coating system (Quorum Technologies 
Q150RS). Imaging was performed at 10kV with a field emission microscope (JEOL 6335F). 
Critical point drying, coating and imaging of the samples was performed at ICTS National Centre 
of Electron Microscopy (UCM, Madrid, Spain). 
 
CXCR2 and CXCR4 cross-inhibition assays 
Wild-type mice were bled, RBC lysed and leukocytes resuspended in RPMI 1640 (Invitrogen). 
Some cells were pretreated with CXCL12 (50 ng/ml, R&D Systems) for 5 minutes at 37ºC while 
others were left untreated. Cells were allowed to migrate towards CXCL1 (50ng/ml, R&D 
Systems) or CXCL2 (50ng/ml, R&D Systems) through 6.5mm transwells with 5μm pore 
polycarbonate membrane insert (Corning, NY, USA), for 1h at 37ºC. Transmigrated cells were 
collected and stained with anti-Ly6G and anti-CD62L antibodies for cytometric analysis. Migration 
to only media was also used as a control. Quantification was performed using Truecount beads, 
as indicated above.  
 
Neutrophil depletion 
In some experiments mice were depleted of neutrophils prior to ischemia/reperfusion. Mice were 
injected 100μg of anti-Ly6G antibody (1A8 clone; BioXCell; West Lebanon, NH) intraperitoneally 
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for 2 consecutive days resulting in >93% reduction in blood neutrophil counts. Lymphocyte and 
monocyte counts were not affected by this treatment (Casanova-Acebes et al., 2013). 
 
Zymosan-induced peritonitis 
Transplantation chimeras or the wild-type partner in parabiotic pairs were treated with zymosan 
(1mg, intraperitoneal injection, Sigma). After 2 h we took blood samples and obtained the 
peritoneal lavage for cytometric analyses and cell count. We compared the ratios of neutrophils 
from each donor in the peritoneum and blood to estimate the migration efficiencies of mutant cells 
(ratio in peritoneum / ratio in blood). We also compared the migration efficiency of neutrophils in 
wild-type mice at ZT5 and ZT13. In this case we measured the absolute number of neutrophils in 
the peritoneal lavage using counting beads (Truecount absolute counting tubes, BD) and 
normalized migration relative to the absolute number of neutrophils in blood.  
For experiments analyzing the dynamics of neutrophil aging during inflammation, we treated wild-
type mice with zymosan (1mg, i.p.) and after 24h we analyzed blood neutrophils twice per day 
(ZT5 and ZT13) for 4 consecutive days. We estimated the absolute number of aged (CD62LLO) 
neutrophils by flow cytometry as indicated above. 
 
Soluble selectin binding assays 
Transplantation chimeras were bled and RBC lysed, then cells washed in RPMI 1640 containing 
5% FBS and stained them using E- or P-selectin/human IgM chimeras as reported (Hidalgo et al., 
2007). Cells were further incubated for 15 min with a FITC-conjugated anti-human IgM (Jackson 
Immunoresearch) and anti-Ly6G-APC (BioXcell) antibodies. Control samples contained 5mM 
EDTA. Cells were analysed in a Sony SP6800 Spectral Analyzer. 
 
Auto-perfused flow chamber assay 
In order to investigate the number of rolling and adherent cells, we used a microflow chamber 
system (Zarbock et al., 2007). 20 x 200 m rectangular glass capillaries were filled with P-selectin 
(50 g/ml) alone or in combination with ICAM-1 (15 μg/ml) and/or CXCL1 (25 g/ml) for 2 hr and 
blocked for 2 hr with 1% casein (Pierce Chemicals, Dallas, TX). One side of the chamber was 
connected to a PE 10 tubing and inserted into the carotid artery. The other side of the chamber 
was connected to a PE 50 tubing and used to control the wall shear stress, which was calculated 
as described (Zarbock et al., 2007). Microscopy was conducted with a Zeiss Axioskop (Carl Zeiss, 
Inc., Thornwood, NY) with a saline immersion objective (SW 20, N.A. 0.5). Recordings were taken 
using an SW40/0.75 objective and a digital camera (Sensicam QE). Capturing on P-selectin was 
analyzed after 2 minutes and chemokine-induced arrest was analyzed after 6 minutes of 
perfusion. 
 
Cortical beta-actin quantification 
Sorted neutrophils were cytospun onto Superfrost Plus microscope slides (Thermo Scientific, 
Waltham, USA) with a Shandon Cytospin 4 (Thermo Scientific) for 5 minutes at 500 RPM in 
medium acceleration. Then cells were fixed with 4% PFA in PBS for 10 minutes and blocked with 
5% goat serum, 5% BSA in saline in a humid chamber for 30 minutes. Finally, cells were stained 
with a rabbit anti-mouse beta-actin antibody (ab8227, Abcam) and with a secondary goat anti-
rabbit antibody conjugated with AF568. Then slides were mounted with Mowiol and captured with 
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Red blood cell-lysed blood was plated in RPMI in 96-well polystyrene microplates (Corning 
Falcon, New York, USA) and stimulated with 50nM of phorbol 12-myristate 13-acetate (PMA) for 
1h. Cells were then stained with 5mM Dihydroethidium (DHE, Thermo Fisher, Waltham, USA) for 
20 minutes and stained for cytometric analysis.  
 
Chemotaxis assay 
Whole blood was harvested and red blood cells were lysed. Cells were plated in 6.5mm 
polycarbonate transwells with 5μm pores (Corning, Corning, USA) in RPMI medium. In the bottom 
well, a single chemokine was added to allow chemotactic migration: 25mg/ml CXCL12 (R&D), 
20ng/ml CXCL1 (R&D), 5ng/ml LTB4 (Tocris), 100mM fMLP (Sigma) or 10ng/ml CCL2 (R&D). 
Transwells were incubated 2h at 37ºC and transmigrated cells were harvested from the bottom 
well and stained for cytometric analysis. The number of transmigrated cells was assessed by the 
presence of a known number of Truecount beads (BD Biosciences). 
 
Multiplex cytokine assay. 
Mice were i.p. injected with Zymosan as indicated above. After 2 hours peritoneal lavages were 
collected and neutrophils stained for FACS sorting. One million sorted neutrophils were incubated 
for 3h in RPMI containing 0.5% BSA and 100,000 heat-killed C. albicans conidia. Supernatants 
were collected and frozen at -80ºC until cytokine quantification was performed. CXCL1, IL-10, IL-
1β, IL-12, TNFα, G-CSF, IL-23, CXCL2, IL-6 and CCL2 were measured in neutrophil supernatants 
using the Mouse ProcartaPlex™ Multiplex Immunoassay (PPX-10-MXTZ766), following the 
manufacturer’s protocol (Thermo Scientific, Waltham, USA). For TGF-β1 detection, samples were 
activated with HCl and measured using commercial TGF beta-1 Mouse ProcartaPlex™ Simplex 
Kit (EPX01A-20608-901). Data acquisition was performed on a MagPix instrument (Luminex Inc, 
Houston, TX) using xPONENT v4.2 software (Luminex) and analyzed with ProcartaPlex Analyst 
software (v1.0; Thermo Scientific). 
 
AMD3100-induced neutrophilia 
2.5mg/kg of AMD3100 (Tocris) was injected intraperitoneally into wild-type mice 1h before 
analysis. Then blood neutrophils were analyzed at ZT5 in an automated hemocytometer (Abacus 
Junior) and stained for cytometric analysis as previously described. At this time (1h after injection 
of AMD3100) we subjected control or AMD3100-treated mice to AMI and Candida albicans 
infection, as previously described. 
 
Neutrophil transfer experiments. 
To increase the yield of fresh neutrophils we used AMD3100-treated mice as neutrophil donors 
(see Figure S5G). To minimize ex vivo manipulation of neutrophils we transferred 200 l of freshly 
extracted blood from donor mice by i.v. injection into host wild-type mice at ZT5. Aging markers 
in host and donor cells were then analyzed 5 minutes and 5 hours after inoculation in the 





For metabolic labelling with 5-Bromodeoxyuridine, mice were intraperitoneally injected with a 
single dose of 2.5mg BrdU (BD Biosciences). Blood samples were collected at indicated times 
and stained for Ly6G, CD62L, CXCR2 and CXCR4, followed by fixation and intracellular labelling 
of BrdU using an APC-conjugated anti-BrdU antibody as per manufacturer’s instructions (BD 
Biosciences). 
 
In vivo CXCL1 and CXCL2 blockade 
For in vivo blockade of CXCL1 and CXCL2, mice were injected intraperitoneally twice with 50μg 
of isotype or monoclonal antibody against CXCL1 (MAB453, R&D) or CXCL2 (MAB452, R&D) the 
night before the analysis (-17h) and the same day (-5h). Blood from treated mice was harvested 
and analysed by flow cytometry as previously described. In a set of mice, intravital imaging was 
performed to analyse neutrophil behaviour in the microvasculature of the cremaster muscle by 
intravital microscopy as previously described.  
 
Cecal ligation and puncture (CLP)-induced sepsis 
CLP was performed as previously described (Rittirsch et al., 2009). Briefly, the peritoneal cavity 
of ketamine/xylazine-anesthetised mice was exposed with a small incision and the cecum was 
exteriorized. 80% of the cecum distal to the ileo-cecal valve was ligated using non-absorbable 7-
0 suture. A 23-gauge needle was then used to puncture both walls of the distal end of the cecum, 
and a small drop of faeces was extruded through the perforation. The ligated and punctured 
cecum was relocated inside the peritoneal cavity and both peritoneum and skin were closed. Mice 
were then treated with s.c. injection of Buprenorphine. Control mice (sham) were included with 
the same procedure but without ligation or puncture. 
 
Evans blue vascular permeability assay. 
To address whether the constitutive presence of fresh or aged neutrophils in the mutant mice 
affected the vascular integrity, we performed vascular permeability assays as previously 
described (Radu and Chernoff, 2013). Briefly, a 0.5% solution of Evans blue in sterile PBS was 
prepared and 200l of the solution was i.v. injected into WT or mutant mice. 5 minutes after the 
transfer mice were sacrificed and tissues extracted and weighted. Then, tissues were submerged 
in 1ml formamide and incubated at 50ºC for 24h. Tissues were removed and the tubes centrifuged 
for 5 minutes at 645 g. Finally, supernatants were measured for absorbance at 610nm using an 
xMark Microplate Spectrophotometer (BioRad) plate reader. The vascular permeability test was 
performed in untreated and LPS-treated (10 mg/kg) mice. 
 
Analysis of endothelial proliferation and apoptosis. 
We processed tissues from WT or mutant mice as previously described (see section Analysis of 
neutrophil clearance in the steady-state) to obtain single cell suspensions. One half of the 
suspension was used to measure apoptosis and the rest to assess proliferation. For proliferation 
we measured Ki67 by intra-nuclear staining in endothelial cells. Cells were stained with anti-CD45 
conjugated with PerCP/Cy5.5 (BioLegend) and anti-CD31-APC (eBioScience) and then fixed and 
permeabilized using the Fix/Perm and Perm Buffers (eBiosciences) according to manufacturer’s 
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instructions. Cells were then stained for 20 minutes at 4ºC with an anti-mouse/rat Ki67 antibody 
labelled with eFluor660 (Thermo Fisher) and analysed by flow cytometry.  
For quantification of apoptotic endothelial cells we measured Annexin V binding and DAPI 
labelling. Cell suspensions were incubated with 1:200 of anti-CD45 and anti-CD31, washed twice 
in cold PBS and resuspended in Annexin V Binding Buffer (10 mM Hepes, pH adjusted to 7.4 with 
NaOH, 140 mM NaCl, 2.5 mM CaCl2) at a concentration of 1 million cells per ml. 100l of this cell 
suspension (1x105 cells) was stained with PE-conjugated Annexin V (Invitrogen) for 15 minutes 
at room temperature in the dark. Finally, 400l of binding buffer containing DAPI was added to 
each tube and analyzed by flow cytometry within one hour. 
 
Analysis of neutrophil aging in microbiota depleted and germ-free mice. 
For microbiota depletion studies we followed a previously published protocol (Zhang et al., 2015). 
Briefly, mice were fed with a cocktail of antibiotics (ABX) including ampicillin (1 g/l), neomycin (1 
g/l), metronidazol (1 g/l) and vancomycin (1 g/l) in drinking water for 4 weeks prior to analysis by 
flow cytometry. For germ-free mice we compared by flow cytometry SPF-housed with germ free 




QUANTIFICATION AND STATISTICAL ANALYSIS 
 
Specific quantification protocols are detailed in each method above. 
 
RNA-sequencing data analysis 
For data analysis, sequencing adaptor contaminations were removed from reads using Cutadapt 
and the resulting reads were mapped on the transcriptome (GRCm38 Ensembl gene-build 70) 
and quantified using RSEM v1.17 (Li and Dewey, 2011). Only genes with at least one count per 
million in at least 2 samples were considered for statistical analysis. Data were then normalized 
and differential expression tested using the Bioconductor package EdgeR (Robinson et al., 2010). 
Raw and Benjamini-Hochberg adjusted p-values were calculated for each of the comparisons of 
interest. Non-adjusted p-values were used to identify overrepresented pathways using Ingenuity 
Pathway Analysis (IPA, Quiagen, www.ingenuity.com). These results were quantitatively 
validated by qPCR analyses for a collection of relevant genes, and functionally validated using in 
vivo assays as detailed in the manuscript. K-means clustering, PCA analysis and heat-map 





Unless otherwise indicated, data are represented as mean values ± standard error of the mean 
(SEM). Paired or unpaired t-test was used when 2 groups were compared, and comparison of 
more than two data sets was done using one-way analysis of variance (ANOVA) with Turkey’s 
post-test. Where applicable, normality was estimated using D’Agostino & Pearson or Shapiro-
Wilk normality test. Log-rank analysis was used for Kaplan-Meier survival curves. Sample 
49 
 
exclusion was not performed unless evident signs of disease were found in a mouse, in which 
case statistically significant outliers were identified using Grubb’s test (ESD method). 
Comparisons of two time curves were performed using two-way ANOVA. All statistical analyses 
were performed using Prism v6 (GraphPad Software, California, USA). A p-value below 0.05 was 
considered statistically significant; non-significant differences (ns) are indicated accordingly.   
 
Amplitude vs zero test 
For determination of diurnal patterns, we performed COSINOR fitting of circadian curves, using 
the curve-fitting module of Graphpad Prism with the equation Y = Baseline + Amplitude x cos 
(Frecuency X + Phaseshift), where Baseline = average of Ymax and Ymin; Amplitude = 0.5 x 
(Ymax – Ymin), Frecuency=0.2618 (2*/24) and Phaseshift= value of X at Ymax. To determine 
whether a diurnal curve displayed an oscillating pattern we used the COSINOR-calculated 
amplitudes and compared them with a hypothetical zero-amplitude curve (i.e. with no circadian 
behaviour) assuming that both curves have identical standard deviations. We finally compared 
the two curves’ amplitudes using unpaired t-test analyses. This analysis gave a better estimation 
of circadian patterns considering all time points rather than comparing only two times. Through 
the text this is termed “amplitude vs zero test”. 
 
DATA AND SOFTWARE AVAILABILITY 
Raw data for the RNA sequencing analyses can be publicly accessed at the Gene Expression 
Omnibus (GEO, NCBI) with GEO Accession Number GSE102310 (for reviewers: 
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE102310; password for reviewers: 




KEY RESOURCES TABLE 
 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
CXCR4-APC (Human) eBioscience Clone 12G5; RRID:AB_1944349 
CD11b-FITC (Human) eBioscience Clone ICRF44 
CD16-Pacific Blue (Human) BD Clone 3G8 
CD62L-PE (Human) BD Clone DREG56 
CD11c-APC (Human) BD Clone B-ly6 
bio eBioscience Clone 1A8 
Ly6G-Dylight 450 BioXcell (conjugated in-house) Clone 1A8; RRID:AB_1107721 
Ly6G-Dylight 650 BioXcell (conjugated in-house) Clone 1A8; RRID:AB_1107721 
Ly6G-FITC eBioscience Clone 1A8; RRID:AB_2572532 
CD45-PerCP-Cy5.5 Biolegend Clone 30-F11; RRID:AB_893344 
CD11b-PE Tonbo Biosciences Clone M1/70; RRID:AB_2621746 
CD11b-FITC BD Clone M1/70; RRID:AB_394774 
CXCR2-PerCP-Cy5.5 Biolegend Clone SA044G4; RRID:AB_2565695 
CXCR4-APC eBioscience Clone 2B11; RRID:AB_10670877 
CD41-PE eBioscience Clone MWReg30 RRID:AB_2538354 
Ly6C-FITC Biolegend Clone HK1.4 
CD62L-APC eBioscience Clone MEL-14; RRID:AB_469410 
CD62L-FITC eBioscience Clone MEL-14; RRID:AB_465109 
Anti-CXCL1 R&D MAB453; RRID:AB_2087696 
Anti-CXCL2 R&D MAB452; RRID:AB_2230058 
Anti-CXCL12 R&D MAB350; RRID:AB_2088149 
Anti-Ly6G (depleting antibody) BioXCell BE0075-1; RRID:AB_1107721 
   
Experimental Models: 
Organisms/Strains 
WT  Charles River C57BL/6 
Mrp8CRE Passegué et al. 2004 B6.Cg-Tg(S100A8-cre,-EGFP)1Ilw 
CXCR2fl/fl  Schloss et al. 2016 C57BL/6-Cxcr2tm1Rmra 
CXCR2∆N This paper N/A 
CXCR4fl/fl  Nie et al. 2004 B6.129P2-Cxcr4tm2Yzo  
CXCR4∆N This paper N/A 
CXCR4WHIM Balabanian et al. 2012 Cxcr4/1013 
Arntlfl/fl  Janich et al. 2011 B6.129S4(Cg)-Arntltm1Weit 
Bmal1∆N This paper N/A 
PEdKO Frenette et al. 1996 B6.129S2-Seletm1Hyn Selptm1Hyn 
DsRED Vintersten et al. 2004 B6.Cg-Tg(CAG-DsRed*MST)1Nagy 
LysM-GFP Faust et al. 2000 B6.129P-Lyz2tm1(EGFP)1.1Graf/Mmmh 
   
Chemicals, Peptides, and 
Recombinant Proteins 





CXCL1 (recombinant) R&D 453-KC 
CXCL2 (recombinant) R&D 452-M2 
TNFα R&D 410-MT-050 
AMD3100 Tocris Cat#3299 
   
Oligonucleotides 
Primers for qPCR, see table S3 This paper N/A 
   
Software and Algorithms 
ImageJ NIH Schindelin J. et al 2015 
Imaris Bitplane RRID:SCR_007370 
Genesis TÜ Graz RRID:SCR_015775 
Prism Graphpad RRID:SCR_002798 
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Figure S1. Patterns of neutrophil aging in humans and mice, related to Figure 1.  
(A) Evidence of aging in human neutrophils. Blood samples from healthy volunteers (n=6 for 
markers; 12 for percent and total aged) were taken at the indicated times, analyzed with a 
hemocounter and by flow cytometry. Top panels, representative cytometry plots of human blood 
samples, gated on DAPINEG, CD11b+, CD16+ neutrophils and further stained for CXCR4 and 
CD62L.  Lower panels show the levels of CD62L and CXCR4 on neutrophils at different diurnal 
times (left panel) which were used to calculate the percentage (middle panel) and total number 
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(right panel) of aged neutrophils. The indicated P values were calculated after Cosinor adjustment 
as indicated in the Methods section (amplitude vs. zero test).  
(B) Diurnal patterns of aging are preserved in constant darkness. The phenotype and number of 
neutrophils was estimated for 4 consecutive days at ZT5 and ZT13 by flow cytometry (CD62L 
staining), in mice maintained under LD (left) or DD (right). Data from n=3-5 mice per time.  
(C) Entrainment of diurnal aging by light. Mice were kept in a 12h light-shift schedule for 3 weeks 
before analyzing the number of aged neutrophils throughout a full diurnal cycle in control or light-
shifted mice. Data from n=5 mice per time. P values were calculated as in (A). 
(D) Validation of diurnally regulated genes in mouse neutrophils. Quantitative PCR of selected 
genes identified from the RNAseq analyses as differentially regulated between ZT5 and ZT13 
(n=3-7). Values are mean ± SEM. *, p<0.0.5; **; p<0.01; ***, p<0.001 as determined by unpaired 
t-test analysis.  
(E) Fold-change expression of genes of the molecular clock pathway as determined from the 
RNAseq analyses of circulating neutrophils purified at ZT5 and ZT13.  
(F) Ex vivo treatment with the CXCR2 agonists CXCL1 or CXCL2 induces downregulation of 
CD62L and CXCR2 on neutrophils; n=4-10. These changes resemble those seen during diurnal 
aging, as shown in Figure 1E.  
Data are presented as mean ± SEM. *, p<0.05; **, p<0.01; ***, p<0.001 as determined by unpaired 






Figure S2. Validation of differentially expressed genes and diurnal regulation of genes of 
the molecular clock pathway, related to Figure 2. 
(A) Depletion of CXCR2, CXCR4 and Bmal1 from neutrophils. To establish specific and robust 
gene-deletion in neutrophils in vivo we tested two different existing drivers. The highly-specific 
Ly6GCRE driver (Hasenberg et al., 2015) is poorly efficient for CXCR2FL/FL excision, as assessed 
by flow cytometry. Instead, the MRP8CRE driver (Passegue et al., 2004) allows efficient deletion 
in CXCR2floxed mice, as shown in the density plots (left); n=4-12 mice per group. 
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(B) Efficient and specific deletion of CXCR4 in CXCR4fl/fl mice using the MRP8CRE driver, as 
determined by flow cytometry of blood neutrophils with isotype or anti-CXCR4 antibodies; n=3. 
(C) Bmal1 protein levels in wild-type and mutant blood neutrophils. For wild-type neutrophils we 
measured protein levels at ZT5 and ZT13. Blots are shown on top, and quantification corrected 
for -actin load control are shown in the bar graphs at bottom; n=3 independent experiments.  
(D) Inhibition of CXCR2 signaling through CXCL12/CXCR4. Wild-type neutrophils were pre-
incubated with CXCL12, a CXCR4 agonist, and then allowed to migrate towards a CXCL1 
gradient. The number of migrated cells and their expression of CD62L was evaluated by flow 
cytometry n=2 (bone marrow) and 5 (blood). 
(E) Analysis of CD62L levels in neutrophils from transplant chimeras of wild-type and CXCR4WHIM 
donors; n = 5 mice. 
(F) Heat map showing the transcriptomic fingerprint of fresh and aged groups, showing coherent 
changes between fresh (ZT13, Bmal1∆N and CXCR2∆N) and aged neutrophils (ZT5 and 
CXCR4N).   
(G) Scatter plots showing signature genes (from Figure S2F) of neutrophils from wild-type, 
Bmal1N or CXCR4N mice, comparing their profiles at ZT5 vs. ZT13. Note that diurnal variation 
in the profile is most prominent for wild-type cells and blunted for CXCR4N and Bmal1N cells. 
(H) Functional pathways differentially regulated both in circulating neutrophils over time (ZT13 vs 
ZT5) and between genetic models (Bmal1N vs. CXCR4N). We used a criterion of –log (p-
value)>1.3 to select these pathways using the IPA package, the most relevant of which are 
indicated. 
(I) Experimental set-up to test the effect of in vivo blocking CXCL1 or CXCL2 on CD62L levels in 
circulating neutrophils from WT:CXCR2N transplantation chimeras; n=3-7. CXCL2 partially 
blocks loss of CD62L in wild-type cells, but has no effect in CXCR2N neutrophils.  
(J) Neutrophil aging after transfer. Experimental set-up and percentage of aged (CD62LLO) 
neutrophils at 5 min and 5h after transfer. Fresh donor cells age over time while host aged 
neutrophil are reduced; n=4 donor and 4 recipient mice. 
Data are presented as mean ± SEM. *, p<0.05; ***, p<0.001; n.s., not significant, as determined 






Figure S3. Migratory properties of fresh and aged neutrophils, related to Figure 3.  
(A) Homeostatic clearance of WT or aged (PEdKO) neutrophils into the tissues of wild-type 
parabiotic partners. WT:WT parabionts were used as reference; n=3-8. 
(B) Migration efficiency of neutrophils into the peritoneum of zymosan-treated wild-type, Bmal1N 
and CXCR4N mice at ZT5 or ZT13. The infiltration efficiency was corrected by the number of 
neutrophils present in the circulation at those times; n=5-7 per group and time. 






Figure S4. Differential rolling and migration of neutrophils at different diurnal times and 
from aging mutants, related to Figure 4. 
(A) Parabiosis of PEdKO with wild-type partners to evaluate the migration of aged (PEdKO) vs 
wild-type neutrophils into inflamed tissues of the wild-type partner. Bars show the fractions of 
neutrophils from each partner that rolled, adhered and extravasated in the microcirculation of 
the inflamed cremaster muscle (TNF-treated); n=28-53 venules for rolling/adhesion, and 
10,021 cells for extravasation, from 3-5 parabiotic pairs.  
(B) Crawling tracks of neutrophils of wild-type, fresh (Bmal1N) and aged (CXCR4N and 
PEdKOGFP) neutrophils within inflamed cremasteric vessels, as assessed by intravital 
microscopy. PEdKO neutrophils were analyzed in the parabiosis setup shown in (A), whereas 
Bmal1N and CXCR4N neutrophils were analyzed from the BM chimeras shown in Figure 3A-B. 
No significant differences were found for velocity, distance or directionality. Data is from 30-61 
cells from 3-6 mice. 
(C) Dynamics of wild-type and aged (PEdKOGFP) neutrophils extravasated into the interstitial 
tissue of inflamed cremaster muscles. Data was obtained from the same animals shown in (A); 
Data is from 30-33 cells from 3 parabiotic pairs.  
(D) Chemotactic efficiencies of wild-type and mutant cells towards common neutrophil 
chemokines and chemoattractants. The dashed line indicates migration to media alone; n=4-11 
replicates.  
(E-F) Diurnal variations in rolling efficiency are neutrophil-intrinsic. (E) Experimental scheme of 
the autoperfused flow chamber. Endogenous wild-type neutrophils roll in a flow chamber coated 
with P-selectin alone, or together with ICAM-1 and CXCL1 to induce adhesion. (F) Rolling and 
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Adhesion efficiencies of neutrophils from mice analyzed in the flow chambers at ZT5 or ZT13; 
n=4 mice per time.  
(G) Selectin ligands in fresh and aged neutrophils. Quantification of selectin binding by 
neutrophils from wild-type mice at ZT5 and ZT13 (left), or from wild-type and mutant mice at 
ZT5 (right); n=4-5 mice per group.  
(H) Immunofluorescence staining of -actin in wild-type, Bmal1N and CXCR4N neutrophils, and 
frequency of neutrophils with cortical distribution of -actin (ZT5); n=122-301 cells per group.  
(I) Scanning electron micrographs of wild-type, Bmal1N and CXCR4N neutrophils, and 
quantification of the number of villi on their surface (ZT5). Scale bar, 2 m; n=26-29 cells per 
group. 
(J) Number of neutrophils at baseline in different tissues of wild-type mice. Note the absence of 
neutrophils in the brain. Values are per ml blood or gram of tissue; n=4 mice. 
(K) Percentage of infarcted brain areas along the rostro-caudal axis, and representative images, 
from wild-type, Bmal1N and CXCR4N mice. Infarcts were performed at ZT5. Asterisks identify 
infarcted areas; n=8-11 mice per group. Bar-graphs at right show the percentage of infarcted 
brain volumes in the groups shown in (K) 
Data are presented as mean ± SEM. *, p<0.05; **, p<0.01; ***, p<0.001, ns, not significant, as 
determined by paired (A, C) or unpaired (D, F, G, H) t-test analysis, or one-way ANOVA with 







Figure S5. Diurnal patterns of circulating neutrophils and responses to infection, related 
to Figure 5.  
(A) Diurnal dynamics of total, fresh and aged neutrophils in wild-type, Bmal1N and CXCR4N 
mice. Neutrophil numbers were obtained with a hemo-counter, and the frequency and absolute 
number of CD62LLO aged and CD62LHI fresh neutrophils estimated by flow cytometry; n = 32-56 
mice per group. Note the different scales across the different groups. Shaded areas correspond 
to night time. 
(B) Survival curves of wild-type mice infected with C. albicans at ZT5 or ZT13 and monitored for 
20 days; n=27-29 mice. P value was calculated by the log rank (Mantel-Cox) test.  
(C) Fungal load at sacrifice in the kidneys of mice shown in (B).  
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(D) Number of neutrophils in naïve kidneys at the indicated times, with values normalized to blood 
counts at each time; n= 5 mice per group.  
(E) Diurnal variations in neutrophil numbers in the circulation of the same mice as (D) at ZT5 and 
ZT13; n=5 mice per time point. 
(F) Neutrophil counts in wild-type mice, wild-type mice treated with AMD3100 and CXCR4N mice 
at ZT5; n=3-4 mice per group. 
(G) Levels of surface CD62L on neutrophils from the mice shown in (F). 
(H-I) Phagocytic efficiency measured as the percentage of phagocytic neutrophils that take up 
fluorescently-labeled heat-killed C. albicans, from wild-type mice at ZT5 and ZT13, or (H) from 
wild-type and mutant mice at ZT5; n=3-6. 
(J) ROS production measured by DHE oxidation by flow as determined by flow cytometry in wild-
type and the indicated mutant neutrophils treated with vehicle or PMA; n = 3 mice. 
(K) Ex vivo cytokine production by neutrophils from the indicated sources and challenged with 
zymosan plus heat-killed Candida; n=4. ND, not detectable. 
(L) Susceptibility to septic shock during cecal ligation and puncture (CLP).  Survival curves of 
wild-type and Bmal1N mice subjected to CLP at ZT5 or ZT13, and followed for 7 days; n=8-20 
mice per group. P values were calculated by the log rank (Mantel-Cox) test. 
Except for (B and L), data are presented as mean ± SEM. *, p<0.05; **, p<0.01; ***, p<0.001, ns, 
not significant, as determined by unpaired (C, D, E and H) t-test analysis, or one-way ANOVA 








Figure S6. Myocardial infarction and intravascular thrombosis in wild-type and mutant 
mice, related to Figure 6. 
(A) Areas at risk of the myocardium in the indicated wild-type and mutant mice subjected to 
ischemia of the coronary artery at ZT5 or ZT13 as indicated, followed by one hour of 
reperfusion. These values correspond to the groups shown in Figure 6B-C.  
(B) Survival curves showing that neutrophil depletion rescues CXCR4N mice from AMI-induced 
death. Wild-type and CXCR4N mice, or CXCR4N mice depleted of neutrophils before being 
subjected to ischemia of the coronary artery for 45 min followed by 24 hour reperfusion. Data 
from 9-11 mice per group. P values compare against wild-type mice using the log-rank test. 
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(C) Intravital images of cremasteric venules re-perfused after 45 min of ischemia, showing 
accumulation of small thrombi within venules of CXCR4N mice, but not in wild-type mice or in 
CXCR4N mice after neutrophil depletion; images are representative of 3 mice. Bar, 10 m. 
(D) Representative images obtained by intravital microscopy of ischemic (top) and reperfused 
(bottom) cremasteric venules from CXCR4N mice treated with vehicle, or the NET inhibitors Cl-
amidine or DNAse I. Note the persistence of micro-thrombi after treatment with either inhibitor, 
indicating that NETs are not responsible for platelet deposition in these mice; n = 3 mice. 
(E) Vascular permeability in wild-type, Bmal1N and CXCR4N mice. Untreated mice (top) or 
LPS- treated mice were injected i.v. with Evans Blue and the presence of the dye in 
homogenized tissues analyzed by absorbance at 610nm; n= 5 per tissue and group. 
(F) Percentage of proliferating CD31+ endothelial cells (EC) in the indicated tissues of wild-type, 
Bmal1N and CXCR4N mice and normalized to the wild-type group; n=4 mice per tissue and 
group. 
(G) Percentage of apoptotic cells in the indicated tissues as measured by annexin V binding in 
EC; n=4 mice per tissue and group. 
(H) Neutrophil phenotype measured by CD62L, CXCR2 and CXCR4 levels in control and 
antibiotics (ABX)-treated WT mice; n= 9-10 mice. 
(I) Neutrophil phenotype in BM chimeras, showing no effect of microbiota depletion (ABX) in the 
aging phenotype of WT and CXCR4N neutrophils; n= 5 mice per group.  
(J) Lack of transcriptional match between neutrophil aging and microbiota-induced gene 
expression, as shown by comparing the microbiota signature (SPF vs GF) with the aging 
signature (see Fig.S2F). RNAseq data from blood neutrophils from 2 SPF vs. 2 GF mice.  
(K) GF mice display the expected neutropenia (left panel), but do not show phenotypic aging 
measured by CD62L levels (right panel); n=3 mice. 
Data are shown as mean ± SEM; *, p<0.05; **, p<0.01; n.s., not significant, as determined by 
unpaired t-test (left panel in A, H, I and K), one-way ANOVA with Dunnett’s multigroup 






Table S1. Complete list of canonical pathways differentially expressed in wild-type 
neutrophils at ZT5 (fresh) vs ZT13 (aged). Related to Figure 1. 
Differentially-regulated pathways (-Log (p value)>1.3) were identified using the Ingenuity 
Pathway Analysis package. Ratios indicate the fraction of differentially expressed genes that 
map to the pathway, out of the total number of genes in that pathway. 
 
Pathway -Log(pvalue) Ratio 
EIF2 Signaling 16,60 0,23 
B Cell Receptor Signaling 12,10 0,20 
iCOS-iCOSL Signaling in T Helper Cells 10,20 0,23 
PKCθ Signaling in T Lymphocytes 9,37 0,21 
Role of NFAT in Regulation of the Immune Response 8,36 0,17 
Regulation of eIF4 and p70S6K Signaling 8,08 0,18 
B Cell Development 7,62 0,36 
mTOR Signaling 7,51 0,16 
PI3K Signaling in B Lymphocytes 7,31 0,18 
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis 6,68 0,21 
IL-4 Signaling 6,27 0,21 
Role of NFAT in Cardiac Hypertrophy 6,19 0,15 
NF-κB Signaling 5,98 0,15 
Chronic Myeloid Leukemia Signaling 5,63 0,18 
HGF Signaling 5,50 0,17 
T Cell Receptor Signaling 5,37 0,18 
CD28 Signaling in T Helper Cells 5,35 0,16 
Renin-Angiotensin Signaling 5,26 0,17 
Calcium-induced T Lymphocyte Apoptosis 4,96 0,20 
SAPK/JNK Signaling 4,92 0,17 
EGF Signaling 4,87 0,21 
Primary Immunodeficiency Signaling 4,81 0,23 
Dendritic Cell Maturation 4,73 0,13 
FcγRIIB Signaling in B Lymphocytes 4,68 0,24 
IL-3 Signaling 4,45 0,18 
T Helper Cell Differentiation 4,45 0,18 
GM-CSF Signaling 4,40 0,19 
Role of JAK1 and JAK3 in γc Cytokine Signaling 4,40 0,19 
IL-2 Signaling 4,38 0,21 
NF-κB Activation by Viruses 4,32 0,18 
IL-6 Signaling 4,31 0,15 
Type II Diabetes Mellitus Signaling 4,31 0,15 
MSP-RON Signaling Pathway 4,21 0,22 
CD40 Signaling 4,19 0,19 
fMLP Signaling in Neutrophils 4,15 0,15 
ErbB2-ErbB3 Signaling 4,07 0,19 
Docosahexaenoic Acid (DHA) Signaling 4,06 0,23 
Ephrin A Signaling 4,05 0,21 
RANK Signaling in Osteoclasts 4,05 0,16 
Telomerase Signaling 4,04 0,15 
Colorectal Cancer Metastasis Signaling 4,01 0,11 
Cardiac Hypertrophy Signaling 4,00 0,11 
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Acute Myeloid Leukemia Signaling 3,95 0,17 
Reelin Signaling in Neurons 3,95 0,17 
PEDF Signaling 3,81 0,17 
Melanoma Signaling 3,80 0,21 
CXCR4 Signaling 3,79 0,13 
Endometrial Cancer Signaling 3,74 0,19 
IL-9 Signaling 3,73 0,24 
Gα12/13 Signaling 3,73 0,14 
GNRH Signaling 3,73 0,13 
Production of Nitric Oxide and Reactive Oxygen Species in 
Macrophages 
3,70 0,12 
NGF Signaling 3,66 0,14 
p70S6K Signaling 3,65 0,13 
Lymphotoxin β Receptor Signaling 3,60 0,19 
Molecular Mechanisms of Cancer 3,59 0,09 
Phospholipase C Signaling 3,58 0,11 
phagosome formation 3,57 0,14 
Non-Small Cell Lung Cancer Signaling 3,54 0,17 
Role of Macrophages, Fibroblasts and Endothelial Cells in 
Rheumatoid Arthritis 
3,51 0,10 
Angiopoietin Signaling 3,48 0,17 
Nitric Oxide Signaling in the Cardiovascular System 3,45 0,14 
Nur77 Signaling in T Lymphocytes 3,40 0,18 
Macropinocytosis Signaling 3,37 0,16 
RAR Activation 3,37 0,11 
Thrombin Signaling 3,37 0,11 
Myc Mediated Apoptosis Signaling 3,34 0,17 
Role of p14/p19ARF in Tumor Suppression 3,30 0,23 
Rac Signaling 3,27 0,14 
Fcγ Receptor-mediated Phagocytosis in Macrophages and 
Monocytes 
3,23 0,14 
Gap Junction Signaling 3,23 0,12 
Prostate Cancer Signaling 3,21 0,15 
Renal Cell Carcinoma Signaling 3,20 0,16 
P2Y Purigenic Receptor Signaling Pathway 3,15 0,13 
IL-8 Signaling 3,15 0,11 
Insulin Receptor Signaling 3,14 0,12 
Melanocyte Development and Pigmentation Signaling 3,11 0,14 
LPS-stimulated MAPK Signaling 3,10 0,15 
CNTF Signaling 3,07 0,17 
IGF-1 Signaling 3,06 0,13 
Gαq Signaling 3,06 0,12 
FLT3 Signaling in Hematopoietic Progenitor Cells 3,05 0,15 
Leptin Signaling in Obesity 3,05 0,15 
Glioma Signaling 3,02 0,13 
Role of Tissue Factor in Cancer 3,02 0,13 
HER-2 Signaling in Breast Cancer 2,95 0,15 
Breast Cancer Regulation by Stathmin1 2,95 0,11 
PDGF Signaling 2,90 0,14 
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Thrombopoietin Signaling 2,89 0,16 
Virus Entry via Endocytic Pathways 2,89 0,14 
Erythropoietin Signaling 2,83 0,15 
Hereditary Breast Cancer Signaling 2,79 0,12 
GDNF Family Ligand-Receptor Interactions 2,78 0,15 
Ceramide Signaling 2,76 0,14 
Autoimmune Thyroid Disease Signaling 2,74 0,17 
CREB Signaling in Neurons 2,74 0,11 
Antigen Presentation Pathway 2,73 0,19 
PTEN Signaling 2,73 0,12 
Clathrin-mediated Endocytosis Signaling 2,73 0,10 
PPAR Signaling 2,72 0,13 
Xenobiotic Metabolism Signaling 2,72 0,09 
Graft-versus-Host Disease Signaling 2,68 0,17 
Glioblastoma Multiforme Signaling 2,67 0,11 
IL-12 Signaling and Production in Macrophages 2,66 0,11 
Glucocorticoid Receptor Signaling 2,65 0,09 
Fc Epsilon RI Signaling 2,63 0,12 
ErbB4 Signaling 2,62 0,15 
LXR/RXR Activation 2,62 0,12 
JAK/Stat Signaling 2,59 0,14 
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid 
Arthritis 
2,59 0,10 
Signaling by Rho Family GTPases 2,58 0,09 
Natural Killer Cell Signaling 2,56 0,12 
FGF Signaling 2,55 0,13 
TR/RXR Activation 2,55 0,13 
AMPK Signaling 2,54 0,10 
PPARα/RXRα Activation 2,54 0,10 
p53 Signaling 2,53 0,12 
Role of Pattern Recognition Receptors in Recognition of Bacteria 
and Viruses 
2,49 0,11 
NRF2-mediated Oxidative Stress Response 2,49 0,10 
Estrogen-Dependent Breast Cancer Signaling 2,47 0,14 
IL-15 Signaling 2,47 0,14 
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza 2,47 0,14 
UVA-Induced MAPK Signaling 2,43 0,13 
DNA Double-Strand Break Repair by Non-Homologous End Joining 2,42 0,29 
Cell Cycle: G1/S Checkpoint Regulation 2,42 0,14 
IL-17A Signaling in Airway Cells 2,42 0,14 
VEGF Family Ligand-Receptor Interactions 2,42 0,13 
G-Protein Coupled Receptor Signaling 2,42 0,09 
Acute Phase Response Signaling 2,41 0,10 
UVB-Induced MAPK Signaling 2,40 0,15 
Leukocyte Extravasation Signaling 2,40 0,10 
Systemic Lupus Erythematosus Signaling 2,37 0,09 
Tec Kinase Signaling 2,36 0,10 
Huntington's Disease Signaling 2,36 0,09 
CCR3 Signaling in Eosinophils 2,32 0,11 
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Regulation of IL-2 Expression in Activated and Anergic T 
Lymphocytes 
2,30 0,13 
Neurotrophin/TRK Signaling 2,29 0,13 
Germ Cell-Sertoli Cell Junction Signaling 2,28 0,10 
IL-10 Signaling 2,24 0,13 
HMGB1 Signaling 2,23 0,11 
Glioma Invasiveness Signaling 2,20 0,14 
Growth Hormone Signaling 2,20 0,13 
GPCR-Mediated Integration of Enteroendocrine Signaling 
Exemplified by an L Cell 
2,12 0,13 
Small Cell Lung Cancer Signaling 2,12 0,13 
Aldosterone Signaling in Epithelial Cells 2,12 0,10 
Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via 
Mevalonate) 
2,09 0,24 
Prolactin Signaling 2,04 0,12 
ErbB Signaling 2,04 0,12 
Toll-like Receptor Signaling 2,01 0,12 
Neuropathic Pain Signaling In Dorsal Horn Neurons 2,01 0,11 
eNOS Signaling 2,01 0,10 
Mitochondrial Dysfunction 2,01 0,09 
Endothelin-1 Signaling 1,98 0,09 
ERK/MAPK Signaling 1,98 0,09 
TREM1 Signaling 1,97 0,12 
Antiproliferative Role of Somatostatin Receptor 2 1,94 0,13 
Communication between Innate and Adaptive Immune Cells 1,94 0,11 
PAK Signaling 1,94 0,11 
CD27 Signaling in Lymphocytes 1,89 0,14 
Acetate Conversion to Acetyl-CoA 1,87 0,50 
IL-1 Signaling 1,87 0,11 
Death Receptor Signaling 1,84 0,11 
VEGF Signaling 1,84 0,11 
Pancreatic Adenocarcinoma Signaling 1,84 0,10 
Relaxin Signaling 1,82 0,10 
Role of IL-17A in Arthritis 1,81 0,13 
Mouse Embryonic Stem Cell Pluripotency 1,75 0,11 
Oxidative Phosphorylation 1,75 0,10 
Sphingosine-1-phosphate Signaling 1,75 0,10 
Actin Cytoskeleton Signaling 1,71 0,08 
Mevalonate Pathway I 1,64 0,23 
Cholecystokinin/Gastrin-mediated Signaling 1,59 0,10 
FAK Signaling 1,58 0,10 
α-Adrenergic Signaling 1,58 0,10 
Ethanol Degradation II 1,57 0,14 
Colanic Acid Building Blocks Biosynthesis 1,55 0,21 
Selenocysteine Biosynthesis II (Archaea and Eukaryotes) 1,50 0,33 
Thioredoxin Pathway 1,50 0,33 
ERK5 Signaling 1,47 0,11 
April Mediated Signaling 1,44 0,13 
VDR/RXR Activation 1,44 0,10 
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Regulation of the Epithelial-Mesenchymal Transition Pathway 1,43 0,08 
Salvage Pathways of Pyrimidine Ribonucleotides 1,42 0,10 
PI3K/AKT Signaling 1,41 0,09 
Granzyme B Signaling 1,39 0,19 
Atherosclerosis Signaling 1,39 0,09 
PXR/RXR Activation 1,38 0,11 
3-phosphoinositide Biosynthesis 1,37 0,08 
B Cell Activating Factor Signaling 1,35 0,13 
Superpathway of Cholesterol Biosynthesis 1,34 0,14 
Corticotropin Releasing Hormone Signaling 1,34 0,09 
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency 1,34 0,09 
Unfolded protein response 1,32 0,11 








Legends to Supplementary Movies 
 
Movie S1. Defective recruitment of aged neutrophils during inflammation. The video 
shows three sequences during the recruitment of neutrophils derived from wild-typeGFP 
(expressing LysMGFP; green) and PEdKORED (expressing DsRed; red) partners, in the 
cremasteric microcirculation of the wild-type partner after TNF treatment. In all steps of 
recruitment (rolling, adhesion and extravasation) wild-typeGFP neutrophils outperform aged 
neutrophils from the PEdKORED partner, even if the initial number of PEdKO-derived neutrophils 
was higher in the free circulation (not shown). In the second sequence (Adhesion), intravascular 
neutrophils are identified by labelling with anti-Ly6G (blue). Movies are representative of 
experiments from 3-5 mice, and are accelerated 3.6-fold for rolling and 24-fold for adhesion and 
extravasation. Quantification for these experiments is provided in Figure S4A. 
 
Movie S2. Firm arrest of neutrophils to the microvasculature in the steady-state does not 
require rolling. Movies were acquired in the naïve dermal microcirculation at ZT9, and 
neutrophils were labelled with a fluorescent anti-Ly6G antibody. Movies at left show three 
examples from wild-type mice; movies at right show neutrophils from mice lacking endothelial 
selectins (PEdKO), in which rolling is impaired. In wild-type animals, rolling preceded but was 
dispensable for arrest, as demonstrated in the selectin-deficient mice. In the absence of 
selectins neutrophils undergo sudden arrest to the vasculature without engaging in rolling, as 
shown in Figure 4F. Dashed lines delineate the vessel wall. Scale bar, 10 m. Movies are 
accelerated 24-fold.  
 
Movie S3. Neutrophil-dependent formation of intravascular thrombi during ischemia-
reperfusion in CXCR4N mice. Ischemia was induced by clamping feeding arteries of the 
cremaster muscle in wild-type or CXCR4N mice for 45 min before reperfusion. Movies were 
acquired during the ischemic and early reperfusion phases. Platelets are labelled with anti-
CD41 antibodies and leukocytes with anti-Ly6G or anti-CD62L plus anti-Ly6C antibodies. 
Thrombi bound to the vessel wall appeared only in the CXCR4N mice, and disappeared when 
neutrophils were depleted (CXCR4N neutrophil-depleted). Scale bars, 10 m. Movies are 
accelerated 24-fold. See also Figure S6C. 
 
Movie S4. Neutrophil aging ensures diurnal defense and vascular protection. Diurnal 
aging of neutrophils released from the bone marrow (fresh neutrophils) is driven by Bmal1 
through control of CXCL2 production and CXCR2 signaling, and is opposed by CXCR4. During 
aging neutrophils alter their surface topology and lose microvilli. As a result, aged neutrophils 
display impaired rolling and recruitment to inflamed tissues, but can naturally migrate to non-
inflamed tissues (homeostatic clearance) through sudden arrest that does not require rolling. 
Aged neutrophils in tissues fight potential infections (C. albicans in kidneys) but can cause 
vascular damage if present in the circulation during ischemia-reperfusion (myocardial infarction). 
Fresh neutrophils that infiltrate inflamed tissues promote damage during sterile tissue 
inflammation (brain ischemia). 
 
